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Abstract 
Older adults with neurocognitive disorders are at high risk for medication non-adherence, 
while being vulnerable to great injury from regimen deviations.  Informal caregivers often aid in 
healthcare management for these individuals.  The current study compared the efficacy of two 
online health education interventions designed to increase caregiver health related knowledge for 
use with care recipients.  Women (N=35) assisting a cognitively impaired older person with 
medications, were randomly assigned to one of two online health education conditions (1) 
narrative vignettes depicting actors encountering common medication challenges, and written 
materials or (2) written materials and didactic video clips of information from medical experts.  
It was hypothesized that narrative group participants would show greater improvements in 
several domains of functioning when compared to didactic group participants.  Results showed 
equivalent participant satisfaction between groups, and that caregivers did not improve 
differentially between condition, over time, in the domains of medication hassles, patient-
provider communication, medication management adherence, or self-efficacy.  There was no 
main effect of time on caregiver reported hassles, patient- provider communication or medication 
adherence.  There was a significant main effect of time on caregiver self-efficacy for controlling 
upsetting thoughts about the caregiving situation F (1, 33) = 8.07, p < .001, p

 = .20, achieved 
power = .79.  Secondary analyses revealed that caregivers in the narrative vignette condition 
showed significant increases in overall self-efficacy for controlling upsetting thoughts, from pre-
treatment (M =  62.95, SD = 33.55), to post treatment (M =  72.38, SD = 31.27), t(17) = -2.53, p 
=.02, as well as within several specific domains of self-efficacy for controlling upsetting 
thoughts.  Future directions include replication of these findings, introducing a no-treatment 
control, and investigation of effective intervention components through dismantling trials. 
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Medication Non-Adherence in Community Dwelling Older Adults with Dementia: An 
Educational Intervention for Family Caregivers 
The U.S. is experiencing an unprecedented shift in age demographics (U.S. Public Health 
Service, 2002).  At present, 35 million older adults live in America, a number which will nearly 
double by the year 2030 (Centers for Disease Control and Prevention and The Merck Company 
Foundation, 2007).  By that time older adults will comprise 18.6% of the population compared to 
12.4% in 2000 (U.S. Census Bureau, 2004), representing one of the fastest growing groups in the 
country.  Although the implications of these shifts for healthcare provision and policies have 
been discussed at great length, less attention has been allocated to medication specific concerns. 
 Medication non-adherence, defined as any deviation from a prescribed regimen capable 
of impacting intended effects, is a pressing behavioral health issue for older adults living in the 
community (Fine et al., 2009).   On average, older adults are diagnosed with three to five chronic 
health conditions (e.g. diabetes, high blood pressure, arthritis) and manage these conditions with 
an average of 5 medications (Center for Disease Control and Prevention and the Merck Company 
Foundation, 2007).  As a result, they are the largest population of medication consumers in the 
U.S. (Center for Disease Control and Prevention and the Merck Company Foundation, 2007). 
Although they comprise 13% of the population, they consume 34% of all prescription 
medications, and 30% of all over-the-counter medications.  In a recent meta-analysis, over 90% 
of studies found increasing numbers of prescriptions to be associated with non-adherence (Vik, 
Maxwell, & Hogan, 2004).  Accordingly, older individuals have more opportunities for non-
adherence than other segments of the population (Ferinni & Ferrini, 2000).  
 Estimates vary slightly, but most projections indicate that over 50% of older adults in the 
community do not follow regimens as prescribed by medical personnel.  One self-report study 
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found that approximately 53% of community dwelling older persons describe themselves as 
medication non-adherent.  Because estimates based on patient self-report do not factor in the 
effects of poor insight and social desirability, a 53% level of non-adherence may represent an 
underestimation of true rates (Roth & Ivey, 2005).  Recent meta-analytic studies that include 
multiple methods of estimation have placed non-adherence at an average rate of 64% in 
community dwelling older adults (Banning, 2009), with the highest estimates at 80% non-
adherence (Center for Disease Control and Prevention and the Merck Company Foundation, 
2007).  Despite variance in prevalence rates, however, data suggest that medication non-
adherence within older adults is alarmingly high.      
 The prevalence of non-adherence is especially concerning when understood in the 
context of negative health consequences, including adverse drug events (ADE).  An ADE is 
defined as “any injury caused by/ or directly related to medication ingestion or errors in 
medication ingestion” (Institute of Medicine, 2007).  These events include allergic reactions, 
fever, confusion, falls, renal failure, liver failure or death.  Such non-adherence related ADEs are 
disquieting in light of age-related physical vulnerabilities (Fried & Walston, 2003).  Unlike other 
populations, older adults have decreased homeostatic reserve; older bodies have more difficulty 
maintaining the physiological balance necessary to fight infections and, more importantly, 
overcome acute or chronic insults (Fried et al., 2003).  Because homeostatic reserve is reduced 
by chronic health conditions, those who are taking the greatest number of medications for these 
conditions are the most vulnerable.  As a result, even small errors in an older person’s 
medication regimen may have catastrophic consequences (Fried et al., 2003).   
 Decreased homeostatic reserve leads to more destructive bodily consequences in older 
adults than in younger adults.  Older individuals are more susceptible to a host of injuries from 
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medications, including allergic reaction, renal/liver failure, excess disability (from frailty), injury 
from falls, death, delirium, depression, confusion, glucose fluctuations and memory impairment 
(Bates, 2007; Beery et al., 2010; Inouye, 2006; Murray & Callahan, 2003).  Many of these 
consequences also have higher chronicity in older adults than younger adults (Bates, 2007; Beery 
et al., 2010; Inouye, 2006; Murray & Callahan, 2003).       
 It is important to note that polypharmacy in older adults combined with medication non-
adherence, may increase the risk for ADEs and the severity of the events (Arnold, 2008). Mixing 
medications in ways other than prescribed may alter dose response as well as organ functioning 
(Arnold, 2008; Schmader et al., 2004). If the individuals taking multiple medications are not 
closely monitored, any side effects related non-adherence and polypharmacy will multiply as a 
function of the time between medication adjustments (Schmader et al., 2004). Further, the use of 
multiple medications, and problems adhering to a prescribed regimen, may increase the 
possibility of adverse medication related events (e.g. hospitalization); one study found that 
approximately 55% of older adults admitted to an ambulatory care setting had experienced at 
least one such instance (Gandhi et al., 2003).      
 In addition, older persons who are medication non-adherent to prescribed regimens have 
poorer global health outcomes than those who are more adherent (DiMatteo, Giordani, Lepper, & 
Croghan, 2002).  Individuals who take medications as directed experience fewer disabilities, and 
enjoy improved chronic health conditions as quantified by changing cholesterol levels, blood 
pressure, glucose, and other objective measures (Banning, 2009; DiMatteo et al., 2002).  Older 
adults who are not taking medications in the manner that they were prescribed can experience 
excess disability such as frailty, ambulatory problems, disability related to exacerbated health 
conditions, and objective decreases in positive indicators of health (Banning, 2009; Bates, 2007; 
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Beery et al., 2010).  These non-adherent individuals also have shorter overall life expectancies 
(DiMatteo et al., 2002).  One study demonstrated that older adults who were prescribed statins, a 
cholesterol lowering drug for diabetes mellitus, had a death rate which was doubled by 
medication non-adherence.  Similarly, older adult patients who were non-adherent on the 
medication Clopidogrel, a drug used to prevent blood clotting while utilizing a drug eluting stent 
for diabetes, showed a death rate which was nine times greater than those who adhered to the 
prescribed regimen (Spertus et al., 2006).         
 With non-adherence and resulting ADEs, individuals can also incur high financial cost 
from increased emergency department admissions, elongated hospital stays, and added physician 
visits or medical testing (New England Healthcare Institute, 2009; Patel & Taylor, 2002).  
Approximately 30% of all hospital visits and 11.4% of emergency room admissions in older 
adults are linked to medication non-adherence (Col, Fanale, & Kronholm, 1990; Schlenk, 
Dunbar-Jacob, & Engberg, 2004).  Additional costs may affect the families of non-adherent 
individuals.  For instance, family members may suffer lost wages due to time spent addressing 
medical repercussions.  On a macroscopic scale, medication non-adherence leads to costs paid by 
the federal government through taxpayer funds (Col et al., 1990; Schlenk et al., 2004).   
Improved medication management, however, could likely reduce these economic costs.   
Medication Non-Adherence in Community Dwelling Older Adults with Progressive 
Neurocognitive Disorders 
 Older adults with Alzheimer’s disease and other neurocognitive disorders are especially 
impacted by medication non-adherence.  Quality of thinking and self-awareness, as well as 
memory and executive deficits can all play a role in medication management concerns. 
Dementia, the primary symptom of many neurocognitive disorders,  is defined broadly as 
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“significant cognitive decline from a previous level of performance in one or more of the 
following domains – complex attention, executive function, learning and memory, language, 
perceptual-motor or social cognition” (American Psychiatric Association, 2013).  Dementing 
neurocognitive disorders are further specified with the following subtypes: Alzheimer’s disease, 
vascular disease, Lewy body disease, neurocognitive change due to a general medical condition, 
cognitive change due to HIV infection, cognitive change due to traumatic brain injury, 
Parkinson’s Disease with cognitive change, Huntington’s disease with cognitive change, Pick’s 
disease with cognitive change, cognitive change due to prion disease, substance induced 
persisting neurocognitive disorder, neurocognitive disorder due to multiple etiologies, 
frontotemporal lobar degeneration and unspecified neurocognitive disorder (American 
Psychiatric Association, 2013).          
 The most common subtypes of neurocognitive disorders present with a progressive 
disease process.  Of the progressive types, Alzheimer’s disease, vascular disease, Lewy body 
disease and mixed etiologies of neurocognitive disorder are the most prevalent.  Alzheimer’s 
disease comprises an estimated 60%-80% of all diagnosed cases and remains the most 
predominant neurocognitive disorder subtype (Alzheimer’s Association, 2012).  Vascular disease 
accounts for an estimated 20-30% of cases while Lewy body disease is presents at a rate of 10-
20% in older adult populations.  Recent studies have shown a high prevalence of mixed 
etiologies for neurocognitive concerns, approximately 50%, upon autopsy (Alzheimer’s 
Association, 2012).  In summary, it is estimated that well over three quarters of all diagnosed 
neurocognitive disorders are progressive in nature.  Accordingly, the use of the terms 
“neurocognitive disorder,” and “dementia,” within this text will refer to the most common 
subtype, progressive, and its impact on medication adherence (Alzheimer’s Association, 2012).  
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 In those with neurocognitive disorders the fundamental symptom of impaired cognition 
places these individuals at increased risk for medication non-adherence.  A common measure of 
cognition, the Mini Mental Status Exam, is the current most frequently utilized evaluation in the 
literature base to gauge the level of this cognitive decline.  Research indicates that community 
dwelling older adults scoring lower on the MMSE have significant difficulty with medication 
adherence.  One study showed that MMSE scores predicted non-adherence in recently 
hospitalized older adults with multiple chronic health conditions (Gray, Mahoney, & Blough, 
2001).  Scores on the MMSE have also been shown to independently predict adherence to 
specific drugs such as anti-hypertensive medications (Salas et al., 2001).  Thus, declining 
cognition has a well-documented relationship to decreased medication adherence in older adults. 
 When compared to older adults who do not exhibit cognitive decline, individuals with 
neurocognitive concerns demonstrate broadly worse levels of regimen adherence (Douglas, 
Letts, & Richardson, 2011).  Persons with diagnosed neurocognitive disorders have been shown 
to lack basic fundamental knowledge regarding their medication regimens (Sela-Katz, 
Rabinowitz, Shugaev, & Shigorina, 2010).  In one study, they evidenced significantly poorer 
knowledge of medication management than their unimpaired age-matched peers.  Approximately 
46.8% of those with a dementing illness lacked basic knowledge about their medication regimen 
while 6.9% of those without dementia lacked such knowledge (Sela-Katz et al., 2010).  This 
study also found that basic knowledge regarding one’s medication regimen declined over time as 
the neurocognitive disorder progressed.  In research examining rates of adverse drug events and 
non-adherence in older adults, post-hoc analysis reveal that cognitive limitations are present in 
the majority of ADE cases (Field, Mazor, Briesacher, DeBellis, & Gurwitz, 2007).  These 
unplanned deviations in prescribed regimens cause more accidental deaths than fires and 
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wandering in persons with dementia (Douglas at al., 2011).  Taken together, this information 
highlights the potential for increased medication non-adherence in community dwelling older 
adults with neurocognitive disorders.       
 Medication non-adherence may also have more significant health consequences for those 
with neurocognitive disorders.  In addition to the reduced homeostatic reserve of older 
adulthood, persons with dementing illnesses are more susceptible to episodes of delirium brought 
about by non-adherence (Fick et al., 2003; Inouye, 2006).  Because dementia is a chronic injury 
to brain functioning, small physiological changes have a higher potential to cause injuries above 
and beyond what is the case for those who age without a dementing illness.  Persons with 
neurocognitive diseases do not easily recover from such physiological insults.  Individuals who 
suffer from delirium superimposed on dementia are at increased risk for accelerated cognitive 
decline, multiple re-hospitalizations, and often, death (Fick et al., 2003; Inouye, 2006). 
 Medication non-adherence in older adults with neurocognitive disorders becomes 
especially pressing in the context of the previously discussed demographics.  At present, it is 
estimated that approximately 5.2 million Americans are affected by some form of dementia, 
most of which are progressive.  By the year 2050, the number of seniors with irreversible and 
incurable dementias will increase to approximately 16 million (Alzheimer’s Association, 2010).  
Thus, the problem of medication non-adherence in older adults with neurocognitive concerns 
will continue to grow.    
Given the likelihood for high prevalence and additional health consequences, medication 
adherence in older adults with neurocognitive disorders is a critical behavioral health issue.  
Despite the need for data and interventions, however, the research in this field is in its infancy.  
What follows is a parallel review of interventions to improve medication adherence in all older 
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adults as well as those with dementia.  The review of the broader older adult population shows a 
larger literature base which serves to highlight our lack of knowledge in those with 
neurocognitive concerns.  The parallel structure also uses data available for older adults as a 
foundation for understanding possible interventions in community dwelling older adults with 
dementia.  Overall, the current data points to the possible efficacy of interventions targeting 
informal caregivers of older adults. 
Adherence Interventions in Community Dwelling Older Adults        
 Current literature shows that successful adherence interventions for older adults can be 
divided into two basic categories: those with behavioral components and those that provide 
psychoeducation.  The more basic of these interventions, behavioral modifications, include pill 
package changes, alarms that cue for medication administration, self-monitoring of symptoms/ 
side effects, self-monitoring of medication administration times, and over-the counter usage.  
 Packaging changes, or recommendations for this modification, are one of the most 
frequently used behavioral interventions.  In these interventions patients are asked to utilize 
containers, such as pill boxes or blister packs, as opposed to their original pill bottles.  The new 
containers provide a daily organization system and hold all medications to be taken on a given 
day or at a specified time within that day.  Although few interventions use package changes as an 
exclusive intervention strategy, meta-analyses across medication types show large effect sizes 
(Cohen’s d = .67) for interventions that discuss blister packaging or pill box organization (Conn 
et al., 2009).  Mean effect sizes for interventions that do not include this behavioral component 
are relatively small (Cohen’s d = .30; Conn et al., 2009).   Despite the benefit of simplicity, 
however, these interventions have several draw backs.  They cannot account for wrong time 
errors nor do they aid in following medication specific administration instructions such as “take 
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with food” (Banning, 2009; Conn et al., 2009; Heneghan, Glasziou, & Perera, 2007).  In order to 
counter difficulties in timing, reminder alarms are often utilized along with packaging changes.  
In these cases, meta-analyses show the average effect size of interventions without alarms to be 
small (Cohen’s d =  .30), whereas interventions that discuss alarms systems with pill packaging 
show a large effect size (Cohen’s d = 1.06; Conn et al., 2009).  The combination of these 
behavioral recommendations appears to be most effective in promoting medication adherence, 
and should be utilized in future health oriented intervention strategies.      
 Another promising behavioral intervention is symptom-monitoring and side-effect 
awareness, coupled with developing follow-up questions for medical staff (Conn et al., 2009).  
This intervention type requires that clients monitor and record their medication usage and that 
they monitor changes in health that may be medication related.  The strategy teaches participants 
to record instances of medication taking behaviors on calendars or other logs, after each 
administration.  Similarly, symptom monitoring requires patients to log positive and negative 
changes in health status which may relate to medication taking behavior (Conn et al., 2009).  
These techniques are typically used in parallel and have been associated with a large effect size 
(Cohen’s d = 1.18) compared to the low mean effect size (Cohen’s d = .30) for all interventions 
(Banning, 2009).  This method, when used correctly, increases patient awareness of their current 
medication/health patterns and may subsequently change patterns of behavior by increasing the 
number and clarity of questions brought to treating personnel (Conn et al., 2009).  These large 
effect sizes indicate that future interventions for medication adherence would best serve patients 
by providing tools to record medication related data, and teaching patients communication 
strategies and useful questions for medical staff.        
 The second class of successful adherence interventions in older adults without cognitive 
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impairment are psychoeducational, and are associated with a moderate effect size (Cohen’s d = 
.48; Banning, 2009).  This intervention type includes a detailed discussion about medication 
purposes, medication management strategies, problem solving surrounding adherence, a 
discussion of how to effectively communicate with medical personnel and recognizing when 
medication administration errors or adverse consequences have occurred (Conn et al., 2009).  It 
is likely that when adherence interventions in older adults combine these psychoeducational 
components and behavioral modifications surrounding pill packaging changes, symptom 
monitoring and alarm systems, they may see increased efficacy (Conn et al., 2009).    
 Adherence interventions in older adults have been demonstrated as effective across 
multiple delivery formats.  Personnel providing these interventions have included physicians, 
pharmacists, nurse practitioners, nurses, psychologists and social workers (Banning, 2009; 
Bouvy et al., 2003; Clifford et al., 2006; Conn et al., 2009).  One aspect of these interventions 
that may be especially attractive is their flexibility in regards to setting of administration 
(Banning, 2009; Conn et al., 2009).  They can be delivered on an inpatient or outpatient basis or 
during home visits and tele-health communications, all with equivalent efficacy (Banning, 2009).  
Delivering these interventions through tele-health mechanisms has been shown to reduce the 
high cost required to pay personnel for time of delivery, and is reported to be convenient for 
patients receiving care (Banning, 2009; Pew Research Center, 2011).    
 Two interventions of differing intensity demonstrate the efficacy of behavioral and 
psychoeducational interventions in flexible formats.  The first study by Clifford and colleagues 
(2006) recruited cognitively unimpaired older adults (N=410) who had recently been prescribed 
a new medication and who had at least one chronic health condition.  These participants were 
randomized to a treatment as usual group or the intervention group. The intervention group 
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received an initial consultation after obtaining their medications and a single phone call, two 
weeks later.  When called, the intervention group was asked questions based on a semi-structured 
adherence interview.  These questions inquired about client adherence patterns and addressed 
questions or difficulties they experienced in remaining adherent.  Pharmacists were allowed to 
deviate from this interview as patients expressed individual concerns, but the most common area 
of consultation was behavioral modifications (reminder alarms and packaging changes), 
symptom monitoring, psychoeducation about side effects, and what questions to ask the 
prescribing professional.  Overall, patients in the intervention group reported higher medication 
adherence (p = .032) and reported fewer medication related difficulties (p = .021) post-
intervention.  This intervention provided evidence that tele-health behavioral modification and 
psychoeducation may be an effective means for improving adherence.      
 The second psychoeducational intervention was a pharmacist led care plan spanning six 
months (Bouvy et al., 2003).  This study included 152 older adult heart failure patients 
prescribed loop diuretics after a hospital visit.  Patients with cognitive impairments were 
excluded from the study.  When filling their prescriptions, patients in the randomized group 
received a semi-structured interview designed to problem solve around medication non-
adherence.  After this interview, the intervention group received 6 monthly consultation phone 
calls designed to answer patient medication questions and provide broadly based behavioral tips 
for adherence.  The treatment as usual group did not receive interviews or phone calls.  All 
patient adherence data was measured by a MEMS device assessing adherence to the diuretic 
regimen.  Patients who received the intervention had significantly fewer days of non-adherence, 
140/7656 days (1.8%), when compared to those who did not receive the intervention at 337/6196 
(5.4%) days of non-adherence.           
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 As such, the literature supports the efficacy of behavioral interventions, tele-
communicated behavioral modification tips, and psychoeducation to increase medication 
adherence.  Nevertheless, the current state of interventions for medication adherence in older 
adults demonstrates two critical weaknesses.  First these techniques have only been utilized in 
cognitively unimpaired older persons.  Second, the majority of these interventions lack clear 
theoretical underpinnings (Conn et al., 2009).  As a result, this manuscript further reviews the 
relatively sparse data regarding medication adherence interventions in older adults with 
neurocognitive disorders.  Afterwards, an intervention that includes explicit theoretical 
underpinnings and addresses weaknesses in present treatment strategies is described.   
Adherence Interventions for Community Dwelling Older Adults with Progressive 
Neurocognitive Disorders 
There is a dearth of literature for adherence interventions in community dwelling 
individuals with dementia.  To date, only one study has implemented a medication adherence 
intervention for this population (Smith, Lunde, Hathaway, & Vickers, 2007).  The study utilized 
a telephone reminder strategy to increase adherence and included those with both mild cognitive 
impairment (MCI) and dementia (N=14).  The individuals received communications from a 
trained research assistant in the morning, at noon and before bed.  The group receiving the 
intervention maintained medication adherence of approximately 80% while those who did not 
receive the intervention exhibited expected dementia related decline to adherence of 62%.  There 
were no significant improvements between baseline medication adherence and post-intervention 
adherence rates.            
 This study represents a pioneering effort in an understudied population, but it 
demonstrated several substantial limitations to generalizability.  Firstly, the majority of 
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individuals in the sample had a diagnosis of mild cognitive impairment.  They did not qualify for 
a full neurocognitive disorder diagnosis as their cognitive declines did not yet impact daily 
functioning.  The remainder of the sample included individuals in the beginning stages of 
Alzheimer’s disease.  This has two implications.  These results may not hold for a true 
population of individuals with diagnosable neurocognitive disorders and this intervention type 
may not be helpful to those in latter stages of the disease process.  Another limitation to 
generalizability is that the individuals with MCI were not divided into amnestic type or non-
amnestic subtypes.  This is important as amnestic individuals have a higher likelihood of 
conversion to full dementia (Alzheimer’s Association, 2012).  Thus, it is unclear what proportion 
of the MCI population had an increased potential for impairment.  Because the majority of the 
sample included individuals with MCI, and because the authors did not assess for type of MCI, it 
is likely that study may not generalize to individuals in the community with full progressive 
neurocognitive concerns.         
 One study that supports this assumption of limited generalizability was designed by Insel 
and Cole (2005).  This study implemented an individually tailored intervention designed to 
increase cues for medication memory in older adults and, thus, improve medication adherence 
(N=27).  For example, if a coffee drinker prepared a pot of coffee in the morning and needed to 
take medication at that time, the pill bottles were placed next to the coffee maker.  This was 
tailored to each individual.  The primary outcome for this research was pill counts.  This 
intervention increased medication regimen adherence in older adults across time from an initial 
level of 64.7% adherence to 78%.  However, when they removed individuals scoring 1 SD below 
age norms on the MMSE (N=6), adherence rates began at 70.6% and were increased to 86%.  
Therefore, removing those who qualified for a dementia diagnosis caused improvement rates to 
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jump drastically.  Taken together, this information implies that interventions focused solely on 
the person with dementia may see low efficacy.  Considering the progressive nature of many 
dementias, this effect may be amplified with time.   
The Role of Informal Dementia Caregivers in Medication Adherence   
Informal caregivers, family, kin, and chosen family, are the most common source of 
assistance for older adults with cognitive limitations (Alzheimer’s Association, 2011; Schulz & 
Martire, 2004).  Approximately 70-80% of individuals with a dementing illness live in the 
community and of those individuals, 75% receive care from a family member or friend  
(Alzheimer's Association and National Alliance for Caregiving, 2004; Office for National 
Statistics, 2005; Schulz & Martire, 2004; US Census Bureau, 2005). A recent national survey 
completed by the Alzheimer’s Association found that 43.5 million adult family/informal 
caregivers care for someone 50+ years of age and 14.9 million care for someone who has 
Alzheimer's disease or other dementia. (Alzheimer's Association, 2011).  Medication 
management is a particularly complex task that frequently falls within the domain of caregiving 
(American Psychiatric Association, 2010; Arlt, Lindner, Rosier, & Rentelnkrus, 2008; Travis, 
Faan, Hsueh-Fen, Kao & Acton, 2005).  Of the 14.9 million dementia family caregivers in the 
U.S., over half report aiding with medication management at some point in the care process 
(Alzheimer’s Association, 2012; American Psychiatric Association, 2010; National Alliance for 
Caregiving in Collaboration with AARP, 2009; Travis, Kao, & Acton, 2005).   
 Although assuming such roles benefits both the patient and families in some ways 
(Hilgeman, Allen, DeCoster, & Burgio, 2007), many who become caregivers pay heavy 
psychological and physical tolls.  (Graesel, 2002; Kam-Mei, & Au, 2011; Schulz, O’Brien, 
Bookwalla, & Fleissner, 1995).  Overall, studies have found that these dementia family 
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caregivers are generally more distressed than caregivers of physically impaired elders (Ory, Yee, 
Tennstedt & Schulz, 2000).  This distress includes high rates of clinical depression and/or 
depressive symptoms (Cassie, & Sanders, 2008; Schulz & Martire, 2004;), high rates of other 
negative emotions such as anger, frustration, burden, and fear (Ory et al., 2000), and other 
indices of distress, such as family conflict over caregiving, significant emotional strain, financial 
hardship, and reduced time for leisure pursuits (Ory et al., 2000; Pinquart & Sorensen, 2003).  
Physical tolls are also pervasive; Vitaliano et al. (2002) and Vitaliano, Young and Zhang (2004) 
found that caregivers had a greater prevalence of heart disease, high blood pressure and 
metabolic syndromes, than non-caregivers of the same age. Still other studies have found 
complaints of bodily aches and pains, greater prevalence of diabetes, allergies, and use of non-
prescription pain medication to be common in dementia caregivers (Coon, et al., 2004; Pinquart 
& Sorenson, 2003).   Approximately 17% of caregivers believe their health, in general, has 
gotten worse since assuming caregiving responsibilities and 17-35% of caregivers report their 
health as fair or poor (Feinberg, Reinhard, & Choula, 2011).  Thus, the stress of the caregiving 
role, which frequently includes medication management, has the potential to produce negative 
mental health consequences in family caregivers.   
Interventions targeting informal caregivers: General and medication related.  
Numerous interventions have been developed to address the distressing effects of caregiving, but 
very few teach specific information for managing the elder’s health and medication.  Of the 
interventions published in the past decade, there have been multiple reviews support the efficacy 
of those designed to reduce stress or improve mood (Brodaty, Green & Koschera, 2003; Schulz, 
Martire & Klinger, 2005; Sorensen, Pinquart & Duberstein, 2002).  A review by Gallagher-
Thompson and Coon (2007) that used strict criteria for identifying psychosocial caregiver 
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interventions as evidence based, found that three categories could be so considered at the present 
time; psychoeducational skill-building programs (e.g., Coon, Thompson, Steffen, Sorocco & 
Gallagher-Thompson, 2003);  psychotherapy (e.g., Gallagher-Thompson & Steffen, 1994); and 
multi-component interventions (those using several distinct types of treatment such as support 
groups plus family meetings and case management; e.g., Mittelman, Roth, Coon & Haley, 2004; 
Zarit & Zarit, 2007).  Psychoeducational interventions, which derive from behavioral and 
cognitive theories and therapies (cf. Beck, Rush, Shaw & Emery, 1979; D’Zurilla, 1986; 
Lewinsohn, 1974; Lewinsohn, Munoz, Youngren & Zeiss, 1986) are often preferred by family 
members.          
 Despite the overall findings that psychoeducational and combination interventions are 
best suited to assuage caregiver stress, there are some components of the caregiving process that 
remain under-researched with a resulting lack of interventions.  One such paucity exists in the 
realm of caregiver based medication management.  Medication management is an especially 
critical component of the caregiving role, as it directly impacts care-recipient health. It can also 
result in hassles and increased caregiver strain (Thornton & Travis, 2003).  Caregivers managing 
medications must be aware of scheduling logistics, timing of administration, safety issues, side-
effects, knowing what to do in an emergency, issues of polypharmacy and information seeking 
when appropriate (Travis et al., 2005).  If any of these processes are not well managed, it could 
result in negative physical consequences for the care-recipient as well as financial and emotional 
consequences for the caregiver (Bates, 2007; Beery et al., 2010; Inouye, 2006; Murray & 
Callahan, 2003).           
 Nevertheless, present literature searches reveal only one treatment study that sought to 
include informal caregivers as an intervention point for medication adherence in 
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neurocognitively impaired older adults (Kamimura, Ishiwata & Inoue, 2012).  Participants were 
providing care to an older adult (> 65 years of age) who had a Clinical Dementia Rating Scale 
score ranging from 0.5 – 1 (N = 18).  The analogue CDR is scored on a five-point scale that is 
meant to describe individuals without neurocognitive concerns (0) and with questionable (0.5), 
mild (1), moderate (2), and severe (3) neurocognitive difficulties.  Caregivers were trained to 
program and fill an electronic pill planner, which included alarms and real-time pill dispensing, 
throughout the day.  They were subsequently instructed to give minimal prompting to the older 
adult about managing their medications.  The older adult’s medication adherence was calculated 
for one week previous to this intervention and after three months of using the electronic pill 
planner, using ratio of total prescribed doses and total number of medication doses taken by the 
care-recipient (verified by pill count).  Results showed that after 3 months of using this device, 
approximately 66% of the care-recipients in this study were taking all of their medication doses 
in a given day (Kamimura, Ishiwata & Inoue, 2012).    
 Although this study demonstrates the potential benefits of including caregivers in 
healthcare interventions, the findings lack generalizability to certain populations.  Namely, this 
intervention only included older adults with questionable or mild cognitive impairment, and it is 
likely that individuals with greater cognitive impairment would demonstrate more difficulty in 
responding to electronic pill planners with reminders.  Caregivers were also required to undergo 
substantial training by nursing staff in order to operate this device; education took place over 
three home visits.  This preparation necessitates a sizeable time commitment for staff and 
caregivers.  Not only is this approach costly, in terms of staff resources, but this may have 
limited external validity in a highly time-pressured caregiver population.    
 Despite the lack of adherence specific interventions, however, current review papers 
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suggest that all treatments designed to impact a care dyad, should include psychoeducation about 
effective communication strategies and education about cognitive impairment in those with 
neurocognitive disorders. These reviews show that interventions targeting specified dyadic 
problems produce decreased caregiver stress, higher satisfaction and greater intervention 
tolerability, when they teach effective interpersonal strategies (Moon & Adams, 2012).   
Additional information, such as clear material describing the causes of confusion in the older 
adult, has the potential to increase ease of medication management and subsequent adherence 
(Alzheimer’s Association, 2012; National alliance on Family Caregiving, 2009).  It opens the 
door for continued dialogue between health professionals and caregivers/care-recipients, and 
may spur caregivers to seek outside support systems to aid in medication management, 
subsequently improving adherence (Alzheimer’s Association, 2012; National alliance on Family 
Caregiving, 2009).            
 Overall, current research suggests that family caregivers may be the most useful primary 
point of contact when developing medication related interventions for those with dementia.  
Cognitive decline as a consistent predictors of medication non-adherence, (Gray et al., 2001; 
Sela-Katz et al., 2010) coupled with the hassles that caregivers experience when managing 
medication (Thornton & Travis, 2003), further underscore this group as the most impactful point 
of treatment.  In addition, interventions that focus on the caregiver have potential to alleviate 
both caregiver strain, and may also positively impact the health of the care-recipient.  Despite the 
need to support cognitively impaired older adults in managing medications, however, there are 
few interventions designed to help dyads achieve this goal, fewer that do so using caregivers as a 
point of intervention, and almost none that do so by developing an intervention with clear 
theoretical underpinnings. 
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Understanding Caregiver Medication Management from a Health Model Framework: 
Bandura’s Theory of Self-Efficacy 
 Bandura’s social cognitive theory attempts to explain the way in which individuals learn, 
and engage in new behaviors.  This theory posits that people acquire a given behavior as a result 
of interactions between internal and external factors.  Internal influences include cognitions, 
transient emotional states, past experiences, expectancies and goals.  External influences refer to 
the context or the social and physical environment an individual inhabits while learning.  
Reciprocal determinism, or the interaction between the person, environment and behaviors, 
influences the manner in which an individual learns a given behavior (Bandura, 2001).  
 Social cognitive theory emphasizes the role of self-efficacy as one of the strongest 
internal states acting upon the acquisition of a new behavior.  Bandura defines self-efficacy as 
the level of confidence one possesses that he/she can perform a given act (Bandura, 1977; 
Bandura, 1982; Bandura, 1997).  It is a behaviorally specific construct that directly impacts one’s 
ability to persist in tasks, despite obstacles.  Self-efficacy also varies across domains; an 
individual can have high self-efficacy in one area and low self-efficacy in another.  Finally, self-
efficacy is influenced by environmental context (Bandura, 1977; Bandura, 1982; Bandura, 1994; 
Bandura, 1997).              
 Self-efficacy beliefs originate from several types of experiences.  Firstly, they develop 
after performance accomplishments.  Performance accomplishments occur when an individual 
successfully executes a behavior.  The individual then believes that they can successfully 
perform future domain related behaviors (Bandura, 1982).  Efficacy beliefs can also develop 
through vicarious experiences.  In these cases, an individual observes someone else successfully 
completing a given activity.  Vicarious experiences are most powerful when the model is a 
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similar other (Bandura, 1977; Bandura, 1982; Bandura, 1994).  Verbal persuasion and 
physiological state changes are the final mechanisms for developing efficacy (Bandura, 1977; 
Bandura, 1982; Bandura, 1997).  The most effective method for increasing self-efficacy is to 
engage in performance accomplishments (Bandura, 1997).  Vicarious learning follows in power, 
whereas verbal persuasion and physiological state changes have the smallest impact on self-
efficacy (Bandura, 1977; Bandura, 1982; Bandura, 1997).      
 Despite the largely domain specific nature of self-efficacy, however, there are five 
scenarios in which efficacy beliefs may generalize.  The first scenario is when two tasks require 
similar sub-skills.  Efficacy beliefs may also generalize when two skills were developed 
simultaneously or when cognitive meta-strategies learned for one skill apply to another.  In 
addition, efficacy beliefs generalize to new experiences when the individual creates similar 
cognitive structures for learning a given behavior.  Finally, one may experience a 
transformational restructuring of beliefs.  For example, someone who undergoes a powerful 
mastery experience may gain the sense that they can overcome a broad array of challenges 
(Bandura, 1977; Bandura, 1982; Bandura, 1997). 
Self-Efficacy Theory applied to medication management.  Self-efficacy beliefs impact 
medication management and health related outcomes across multiple populations.  In adults age 
18-64, self-efficacy for medication management relates to increased ability to perform 
medication management behaviors.  A study by Brus and colleagues (2000) examined the 
relationship between self-efficacy for adherence to sulphasalazine (a drug for rheumatoid 
arthritis) and a pill count measure of adherence.  Logistic regressions classifying adults as 
adherent or non-adherent, with a cutoff of 80% adherence, showed self-efficacy was a significant 
predictor of adherence behavior.  A similar study by Gifford and colleagues (2000) demonstrated 
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that levels of self-efficacy for managing two multidrug antiretroviral HIV regimens accurately 
classified individuals as having excellent adherence (100%), fair adherence (80-99%) and poor 
adherence (< 80%). It also showed that adherence and self-efficacy related to lower plasma 
concentrations of the HIV virus.  In addition, self-efficacy is linked to adherence with other 
behavioral regimens recommended by physicians.  In a recent study, (N=463) individuals with 
diabetes were shown to be more adherent to physician recommended diet and exercise when they 
reported high self-efficacy for following health related regimens, and higher self-efficacy for 
managing distressing emotions around these health based changes (King et al., 2010).   
 The relationship between self-efficacy and medication adherence extends across age 
groups.  In a population of older adults who experienced a transient ischemic attack (TIA) or 
stroke, those who reported higher self-efficacy for controlling thoughts about medication 
management showed greater levels of medication adherence.  Level of self-efficacy and 
adherence related to a higher likelihood of meeting target glucose/cardiac outcomes (Ireland, 
Arthur, Gunn, Oczkowski, 2010).  Similarly, older adults with high self-efficacy demonstrate 
greater ability to manage osteoporosis medications and exhibit improved medical outcomes 
(Resnick, Wehren, & Orwig, 2003).  Additional data demonstrate that self-reported medication 
adherence is significantly associated with self-efficacy for remembering to administer 
medication (Mcdonald-Miszczak, Maris, Fitzgibbon, & Ritchie, 2004).    
 Finally, numerous studies show that self-efficacy relates to medication management, 
across cultures.  Lewis (2011) demonstrated that low income African Americans with high self-
efficacy for positive medication related behaviors and high self-efficacy for managing emotions 
surrounding health conditions, exhibited greater adherence and better overall communication 
with medical providers.  HIV positive patients recruited from a hospital in Hong Kong, who 
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reported higher self-efficacy for their medication regimen, also demonstrated higher self-
reported medication adherence (Mo, & Mak, 2009).  Israeli patients managing oral and injected 
medications for diabetes exhibited the same pattern: higher self-efficacy related to increased 
ability to manage medications (Mishali, Omer, & Heymann, 2010).  Lastly, medication 
adherence efficacy in Taiwanese organ transplant patients predicted higher levels of medication 
adherence post-transplant (Weng, Dai, Huang, & Chiang, 2009).      
 Social Cognitive Theory and a caregiver based intervention.  At present, no other 
model exists which reliably predicts improved medication management across age groups and 
ethnicities (Bandura, 2004; Conn et al., 2009; Jackson, 2011).  Further, self-efficacy based 
interventions are easily tailored to individual concerns.  Bandura (2004), notes that each 
individual has a unique level of pre-existing efficacy as well as a unique set of obstacles and a 
differing course of progress.  He also explains that this model allows for interventions 
administered in a variety of modalities (Bandura, 1998; Bandura, 2004).  As a result, 
interventions based in self-efficacy theory allow for flexibility in content and administration.  
These facets may be highly beneficial to informal dementia caregivers. 
  The Current Study: Specific Aims and Hypotheses 
The primary aims of this study were to examine the efficacy of a web based intervention 
that utilized Bandura’s theory of self-efficacy and targeted dementia family caregivers.  In this 
study, a multimedia health education condition based on enacted true-to-life vignettes was 
predicted to increase caregivers’ medication management self-efficacy through observational 
learning of similar others. The same information and suggestions delivered in traditional voice 
and written text of experts formed the didactic comparison condition. Expert testimony has been 
demonstrated to be far less effective in shaping self-efficacy beliefs and effective behaviors 
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(Bandura, 1997), while interactive vignettes maximize participants’ engagement with the online 
educational materials (Epstein, Collins, Thomson, & Pancella,  2007; Epstein & McGaha, 1999; 
Epstein, Thomson, Collins, & Pancella, 2009). Because women are disproportionately likely to 
provide medication assistance to aging family members, this intervention focused on female 
caregivers (U.S. Bureau of the Census, 2005).   
This intervention utilized an internet based modality that encompassed the 
psychoeducational and behavioral content areas previously highlighted as effective in the older 
adult, cognitively impaired older adult, and caregiver literature.  This internet modality was 
selected because tele-health interventions demonstrate high efficacy for improving medication 
related behaviors and may be particularly well suited to the busy schedules of informal 
caregivers (Steffen & Mangum, 2003). In addition, internet-based services create access for 
underserved rural caregivers (Steffen & Mangum, 2003).  Finally, the internet has become an 
important source of health information, with eighty percent of internet users, and fifty-nine 
percent of the US population, searching online for health material (Pew Research Center, 2011). 
The proportion of adults aged 65 and older who use the internet to search for information has 
grown to 53%; of these, 70% report going online daily (Pew Research Center, 2011). Thus, the 
internet is a viable and convenient medium for providing flexible and accessible health 
education; such flexibility is linked to the success of recruitment and retention in health 
education and intervention research (Coday et al., 2005).  
Specifically, the goals of this online health education intervention were to increase 
positive behaviors associated with effective medication management strategies by women caring 
for a cognitively impaired older relative/friend and to decrease medication-related caregiving 
hassles.  The hypotheses that were examined are as follows: 
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Compared to participants in the traditional online health education condition, dementia 
caregivers assigned to the narrative vignette condition would:  
1). Report higher levels of satisfaction with the intervention at the post-intervention 
assessment   (1 month).  
2). Show a greater pre to post-intervention decrease in medication refill and 
administration hassles. 
3). Show a greater pre to post-intervention increase in self-reported positive 
communication behaviors with medical providers. 
4). Show a greater pre to post-intervention decrease in medication non-adherent 
behaviors for care-recipient medication regimens. 
5) Show greater pre to post-intervention increases in self-efficacy for controlling 
upsetting thoughts related to the caregiving situations. 
Methods 
Participants 
  Eligible participants were (a) women aged 18 years and older, who (b) assisted a 
community-dwelling biological or “chosen” earlier-generation relative by (c) 
accompanying/providing transportation to a medical appointment of this relative at least once in 
the past year and who (d) were engaging in at least one of the following caregiving activities 
related to prescription drugs: Ordering, retrieving, organizing or administering medication, 
routinely reminding the older adult to take medications, or sharing in decision-making with care 
recipient and physician to begin, hold, increase, decrease, or discontinue a medication and who 
(e) endorsed a score of 2, “somewhat distressed,” or more, on two items of the Family Caregiver 
Medication Administration Hassles Scale (Travis et al., 2003). Similar criteria have been used 
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successfully in research on medication administration by family members of older adults (Travis 
et al., 2003). This definition of caregivers is culturally sensitive to women who provide 
significant care for non-relatives from a previous generation (e.g., caring for “fictive kin,” 
neighbors, and church members in African American communities, as well as for older gay men 
and lesbians who may not have access to support from biological family members). 
  Care-recipients were required to have a caregiver reported diagnosis of dementia.  
Additional inclusion criteria for the care recipient were no lifetime reported history of (b) 
schizophrenia, (c) bipolar disorder, (d) suicide attempts, (e) Huntington’s Disease, (f) 
Korsakoff’s Disease, (g) Multiple Sclerosis, (h) HIV, (i) traumatic brain injury or (j) drug/ 
alcohol dependence.  
Recruitment. All assessment and intervention tasks were conducted online (with 
available telephone technology support), which allowed for local and nationwide recruitment, 
using a variety of strategies. The project advertised on the electronic newsletters and websites for 
local and national agencies serving older adults (e.g., Family Caregiver Support Programs of 
Area Agencies of Aging) and family caregivers (e.g., National Family Caregiver Association, 
Alzheimer’s Association TrialMatch research registry, online family caregiver chat rooms and 
groups). This study also utilized the lab’s Constant Contact (online newsletter service) database 
generated during a prior Express Scripts measurement development study, for individuals who 
indicated interest in receiving information about other research.  In addition, the lab created an 
active Facebook page and twitter account which advertised the link for the screening survey.  
Only “followers” or “friends” on these social media sites were able to see these messages to 
minimize non-caregiver responses to the screening survey.  Followers of these social media sites 
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exclusively included nationwide agencies for aging individuals (e.g. Alzheimer’s Association 
chapters across multiple states). 
In addition to these electronic methods for recruitment, lab members advertised this study 
in-person during the St. Louis, St. Charles, Edwardsville and Rolla Walk to End Alzheimer’s 
events.  This study also provided recruitment materials at all Alzheimer’s Association Care and 
Conquer talks.  In addition, presentations were made about the study to Alzheimer’s Association 
Faith Ambassadors in the St. Louis area as well as to staff at the St. Louis College of Pharmacy.  
Alzheimer’s Association Respite Care Families were also mailed recruitment flyers. 
Study Participants 
Flow of participants through the study.  A total of 467 individuals were screened 
before entry into this study and of those 467 individuals, 54 (11.56%), were eligible for the 
intervention.  One individual was removed before randomization due to a non-working email and 
only initials given for the name.  Thus, 53 individuals, 11.35%, were randomized to the 
experimental narrative vignette treatment condition, or the comparison didactic condition.  Of the 
53 caregivers randomized, 25 were assigned to the comparison didactic condition (47.17%) and 
28 (52.83%) were assigned to the experimental condition (Table 1).   
As shown in Table 1, caregivers who were enrolled in the intervention, at pre-treatment, 
ranged in age from 26 to 56 (M = 53.43, SD = 9.88). These individuals identified as primarily 
White (75.5%), followed by African American (15.1%), Multiracial (7.5%), and Latina (1.9%).  
The large majority of these caregivers stated that they were caring for a parent (88.6%).  Marital 
status was approximately evenly divided, with 56.6% stating that they were married or living as 
married.  This sample of caregivers was well educated, with the average years of education 
equivalent to a bachelor’s degree (M = 16.01, SD = 2.44).  About 34% of this sample earned 
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between $10,000 - $50,000 a year, while the remaining 66% earned over $50,000 each year.  
Individuals entering the intervention reported caring for their loved one for an average of 3.52 
years (SD = 2.40).  These caregivers reported that, at the time of the survey, they provided about 
72% of all of their loved one’s total care. 
As shown in Table 2, participants entering the intervention were providing care to 
individuals who demonstrated moderate levels of impairment on the IADL, ADL and CDR 
(IADL: M = 1.06, SD = 1.42; ADL: M = 3.02, SD = 2.46; CDR: M = 1.45, SD =.80).  The most 
common neurocognitive diagnosis was Alzheimer’s disease (47.2%), however many individuals 
did not know the exact diagnosis of the older adults cognitive difficulties (37.7%).  
Approximately 9.4% of participants reported caring for someone with vascular dementia.  These 
caregivers endorsed managing an average of about 7 prescription medications and 4 over the 
counter medications (Rx Meds: M = 7.37; SD = 3.66; OTC Meds: M = 3.51, SD = 1.89).  The 
most common medical conditions in the care-recipient group, aside from dementia, were high 
blood pressure (69.8%) and arthritis (45.3%). 
No demographic differences in caregiver age, years of education, level of involvement, 
numbers of medicines managed, the relative risk of medicines managed, or current mental health 
status, emerged when comparing narrative vignette participants to didactic group participants, at 
the initial assessment time point (Tables 1 and 2). Similarly, care-recipients were equivalent on 
all demographic variables, including types of medical diagnoses, level of impairment and living 
arrangements, as reported by the caregiver.  Although no demographic differences between 
groups reached significance, some non-significant trends emerged.  Overall, the narrative 
experimental group showed a lower ratio of enrolled African American participants, at 7.1%, 
compared to 24% in the comparison control group (p = .10).  In addition, caregivers in the 
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experimental group reported that they were caring for individuals with slightly higher levels of 
functionality in IADLs, (p = .17; Control M = .80, SD = 1.15; Experimental M = 1.29, SD = 
1.61).  Nevertheless, these groups were equivalent on all examined demographic variables. 
In order to further assess the equivalency of these two groups on primary outcome 
variables, independent t-test were run to compare the narrative vignette and comparison didactic 
conditions on initial levels of hassles, self-efficacy, medication adherence behaviors and patient-
provider communication (Table 3).  Several significant differences emerged in the data.  
Caregivers in the comparison didactic group reported that they were experiencing overall higher 
number of hassles than those assigned to the narrative vignette condition (didactic M = 37.40, SD 
= 26.21; narrative vignette M = 27.57, SD = 17.76; p = .01; Cohen’s d = .51).  When examined 
based on subscales, independent t-tests found that two areas of hassle were driving this overall 
difference.  Caregivers in the didactic comparison condition reported that they were significantly 
more hassled in the areas of Safety (didactic M = 7.36, SD = 6.42; narrative vignette M = 4.68, 
SD = 3.94; p = .01; Cohen’s d = .44) and polypharmacy (didactic M = 6.04, SD = 4.30; narrative 
vignette M = 3.43, SD = 2.91; p = .03; Cohen’s d  = .72) but not in the domains of information 
seeking or scheduling logistics.  Caregivers did not show any significant differences between the 
narrative vignette condition and comparison didactic on initial levels of Self-Efficacy for 
Controlling Upsetting Thoughts, medication adherence as measured by the Moriskey Medication 
Adherence Scale, or caregiver communication with medical providers.   
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Table 1. 
Pre-intervention Caregiver Demographic Characteristics; Total and Comparison of Conditions. 
   
Intervention Group 
 
 
Intervention Group 
Comparison 
 
Variable 
 
Total       
(N = 53) 
 
Didactic   
(n = 25) 
 
Narrative 
(n = 28) 
 
F or 
χ2 
 
 
P Value 
 
Age  
(M, SD) 
 
 
53.43 
(9.88) 
  
53.92 
(9.05) 
 
53  
(10.7) 
 
.92 
 
.34 
Years of Education  
(M, SD) 
 
16.01 
(2.44) 
15.84 
(2.09) 
16.17 
(2.75) 
 
.91 
 
.35 
DASS 21 score (M, SD)      
     Depression 4.89 (4.24) 4.68 (3.72) 5.00 (4.73) .90 .35 
     Anxiety 2.89 (3.19) 2.80 (3.41) 2.90 (3.03) .04 .84 
     Stress 7.24 (4.64) 7.60 (4.62) 6.93 (4.73) .30 .59 
 
Total Time as Caregiver in years  
(M, SD) 
 
3.52 (2.40) 
 
3.94 (2.06) 
 
3.32 (2.58) 
 
.91 
 
.35 
 
What Percent of Total Care Provided 
(M, SD) 
 
72.28 
(29.02) 
 
77.56 
(26.53) 
 
69.17 
(29.12) 
 
.47 
 
 
.50 
 
Ethnicity n, % 
    
6.35 
 
.10 
     Caucasian 40 (75.5%) 15 (60%) 25 (89.3%)   
     African American 8 (15.1%) 6 (24%) 2 (7.1%)   
     Latina 1 (1.9%) 1 (4%) 0   
     Multiracial 4 (7.5%) 3 (12%) 1 (3.6%)   
 
Married/ Living as married n, (%) 
 
30 (56.6%) 
 
13 (52%) 
 
17 (60.7%) 
 
.93 
 
.37 
 
Relationship to Care Recipient n (%) 
    
3.27 
 
.52 
     Daughter 47 (88.6%) 23 (92%) 24 (85.7%)   
     Granddaughter 3 (5.7%) 2 (8%) 1 (3.6%)   
     Aunt/ Uncle 1 (1.9%) 0 1 (3.6%)   
     Close Friend 2 (3.8%) 0 2 (7.1%)   
 
How Caregiver Helps with 
Healthcare, n (%) 
     
     Order Medications 48 (90.6%) 24 (96%) 24 (85.7%) .31 .58 
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     Pick Up Medications 49 (92.4%) 24 (96%) 25 (89.3%) .85 .37 
     Drive to Medical Appointment 52 (98.1%) 25 (100%) 27 (96.4%) .91 .34 
     Help Organize Meds 51 (96.2%) 25 (100%) 26 (92.9%) 1.87 .17 
     Help Decide When to Change  
     Dose 
44 (83%) 22 (88%) 22 (78.6%) .83 .37 
     Help Decide When to Start Med 46 (86.8%) 23 (92%) 23 (82.1%) 1.11 .29 
     Actually Give the Medications 44 (83%) 22 (88%) 22 (78.6%) .83 .37 
     Participate in Medical  
     Appointments 
 
52 (98.1%) 
 
25 (100%) 
 
27 (96.4%) 
 
.91 
 
.31 
 
Income, n (%) 
    
9.02 
 
.53 
     Less than $5000 0 0 0   
     $5,000 - $9,999 0 0 0   
     $10,000  $14,999 3 (5.6%) 1 (4%) 2 (7.1%)   
     $15,000 - $19,999 3 (5.6%) 1 (4%) 2 (7.1%)   
     $20,000 - $20,999 4 (7.5%) 2 (8%) 2 (7.1%)   
     $30,000 - $39,999 8 (15.1%) 5 (20%) 3 (10.7%)   
     $40,000 - $49,000 5 (9.5%) 1 (4%) 4 (17.9%)   
     $50,000 - $59,000 5 (9.5%) 3 (12%) 2 (7.1%)   
     $60,000 - $69,999 5 (9.5%) 3 (12%) 2 (7.1%)   
     Over $70,000 20 (37.7%) 9 (36%) 11 (39.4%)   
 
Employment Status, n (%) 
    
1.27 
 
.74 
    Retired 10 (18.9%) 4 (16%) 6 (21.4%)   
     Working Full Time 25 (47.2%) 12 (48%) 13 (46.4%)   
     Working Part Time 6 (11.3%) 2 (8%) 4 (14.3%)   
     Unemployed 12 (22.6%) 7 (28%) 5 (17.9%)  
 
 
* = p < .05. 
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Table 2 
Pre-intervention Care-Recipient Demographic Characteristics; Total and Comparison of 
Conditions. 
   
Intervention Group 
 
 
Intervention Group 
Comparison 
 
Variable 
 
Total          
(N = 53) 
 
Didactic        
(n = 25) 
 
Narrative      
(n = 28) 
 
 
F or χ2 
 
 
P Value 
 
 
Age (M, SD) 
 
 
83.02 (8.05) 
 
83.00 (6.83) 
 
83.03 (9.12) 
 
1.71 
 
.20 
Years of Education (M, 
SD) 
 
 
12.39 (2.53) 
 
12.08 (2.66) 
 
12.68 (2.41) 
 
.01 
 
.94 
Care Recipient IADL 
score (M, SD) 
 
 
1.06 (1.42) 
 
.80 (1.15) 
 
1.29 (1.61) 
 
1.98 
 
.17 
Care Recipient ADL score 
(M, SD) 
 
 
3.02 (2.46) 
 
2.96 (2.58) 
 
3.07 (2.40) 
 
.64 
 
.43 
Care Recipient CDR 
Score (M, SD) 
 
 
1.45 (.80) 
 
1.44 (.79) 
 
1.46 (.81) 
. 
03 
 
.86 
HBLQ Score (M, SD) 3.87 (1.36) 4.08 (1.32) 3.69 (1.39) .60 .44 
 
Total Number of Rx 
Medications (M, SD) 
 
 
7.37 (3.66) 
 
7.76 (3.91) 
 
7.03 (3.47) 
 
1.20 
 
.28 
Total Number of OTC 
Medications (M, SD) 
 
3.51 (1.89) 
 
3.32 (1.84) 
 
3.68 (1.94) 
 
.18 
 
.67 
 
Gender, n (%) 
    
.05 
 
.82 
     Male 12 (22.6%) 6 (24%) 6 (21.4%)   
     Female 41 (77.4%) 19 (76%) 22 (78.6)   
 
Medical Problem, n (%) 
    
 
 
     Arthritis 24 (45.3%) 13 (52%) 11 (39.3%) .86 .35 
     Spinal/ Back Problems 7 (13.2%) 2 (8%) 5 (17.9%) 1.12 .29 
     Diabetes 13 (24.5%) 7 (28%) 6 (21.4%) .31 .58 
     High Blood Pressure 37 (69.8%) 18 (72%) 19 (67.9%) .11 .74 
     Other Cardiovascular  17 (32.1%) 8 (32%) 9 (32.1%) .00 .99 
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     Cancer 1 (1.9%) 1 (4%) 0 1.14 .29 
     Pulmonary 7 (13.2%) 4 (16%) 3 (10.7%) .32 .70 
     Vision 17 (32.1%) 8 (32%) 9 (32.1%) .00 .99 
     Heavy Alcohol Use 3 (5.7%) 1 (4%) 2 (7.1%) .24 .62 
     Depression 21 (39.6%) 10 (40%) 11 (39.3%) .00 .96 
     Anxiety 16 (30.2%) 6 (24%) 10 (35.7%) .86 .35 
 
Living Arrangement, n 
(%) 
   2.31 .51 
     With Caregiver 24 (45.3%) 13 (52%) 11 (39.3%)   
     In Own Home, Alone 13 (24.5%) 6 (24%) 7 (25%0   
     In own Home, with    
     other 
13 (24.5%) 4 (16%) 9 (32.1%)   
     With Another Relative 3 (5.7%) 2 (8%) 1 (3.6%)   
 
Care Recipient Dementia 
Subtype, n (%) 
    
4.99 
 
.41 
     Don’t Know 20 (37.7%) 7 (28%) 13 (46.4%)   
     Alzheimer’s Disease 25 (47.2%) 14 (56%) 11 (39.3%)   
     Vascular 5 (9.4%) 3 (12%) 2 (7.1%)   
     Lewey Body 2 (3.8%) 1 (4%) 1 (3.6%)   
     Parkinson’s Disease 1 (1.9%) 0 1 (3.6%) 
 
  
* = p < .05. 
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Table 3 
Pre-intervention Comparison between Conditions on Primary Outcome Variables 
 
Variable 
 
Didactic      
(n = 25) 
 
Narrative     
(n = 28) 
 
 
F  
 
P 
Value 
 
Cohen’s 
d 
 
Hassles: Information Seeking 
Subscale (M, SD) 
 
13.04 (9.80) 
 
10.25 (7.53) 
 
1.70 
 
.98 
 
.32 
 
Hassles: Scheduling Logistics 
Subscale (M, SD) 
 
11.00 (8.22) 
 
9.21 (7.31) 
 
.56 
 
.48 
 
.23 
 
Hassles: Safety Subscale (M, SD) 
 
7.36 (6.42) 
 
4.68 (3.94) 
 
8.24 
 
.01* 
 
.51 
 
Hassles: Polypharmacy Subscale 
(M, SD) 
 
6.04 (4.30) 
 
3.43 (2.91) 
 
4.85 
 
.03* 
 
.72 
 
Hassles: Total (M, SD) 
 
37.40 (26.21) 
 
27.57 (17.76) 
 
6.75 
 
.01* 
 
.44 
 
 Self-Efficacy for Controlling 
Upsetting Thoughts: Total (M, SD) 
 
61.37 (26.25) 
 
63.23 (33.76) 
 
3.32 
 
.074 
 
.06 
 
Morisky Medication Adherence 
(M, SD) 
 
 
2.80 (1.58) 
 
2.14 (1.60) 
 
.01 
 
.92 
 
.42 
Stanford Patient Communication 
(M, SD) 
 
3.54 (.95) 2.96 (1.31) 1.74 .19 .51 
* = p < .05. 
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Analysis of Participant Dropout.  Individuals who did not complete the post-
intervention assessment (n = 2), those who never logged into the intervention website (n = 11), 
and those who did not log in and did not complete the second assessment (n = 5), were 
considered treatment non-completers (Table 4).  Of the total participants randomized to the 
control didactic condition (n=25), 72% (n = 17) were categorized as treatment completers using 
the aforementioned criteria.  A total of 61% (n = 18) of all participants randomized to the 
experimental narrative vignette condition (n = 28), were considered to be treatment completers.  
No significant differences in dropout rates emerged between the didactic and narrative vignette 
conditions χ2(1, N = 53) = 0.75, p = .38.  
Using independent sample t-tests and Chi Square tests of independence, treatment 
completers and treatment non-completers, were compared on several demographic variables and 
primary outcome measures (Table 5). Several significant differences arose. Participants who 
dropped out of treatment were caring for individuals who were less impaired than those who 
completed treatment, as shown by caregiver reported CDR scores (p < .001; Completers M = 
1.59, SD = .90; Non-Completers M = 1.19, SD = .46), and caregiver reported ADL scores (p = 
.05; Completers M = 2.68, SD = 2.58; Non-Completers M = 3.67, SD = 2.14).  Participants who 
dropped out of treatment were reporting poorer medication management adherence than 
caregivers who completed the intervention (p = .02; Completers M = 2.40, SD = 1.38; Non-
Completers M = 2.56, SD = 2.03).  Those who dropped out of treatment were also reporting 
higher overall level of medication related hassles (p = .04; Completers M = 31.54, SD = 24.31; 
Non-Completers M = 33.56, SD = 18.99).  Specifically, treatment non-completers endorsed more 
difficulty on the hassle subscale associated with polypharmacy than treatment completers (p < 
.001; Completers M = 4.62, SD = 4.31; Non-Completers M = 4.72, SD = 2.74).  There were no 
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additional differences between treatment completers and non-completers on other demographic 
variables, such as caregiver age, level of education, mental health symptomatology, level of care 
provided, total years providing care, ethnicity, income, employment status or complexity of the 
medication regimen they managed.  There were no other differences between treatment 
completers and non-completers on primary outcome variables, including self-efficacy for 
controlling upsetting thoughts or patient provider communication.  To visually review this 
description of participant flow through the study, see Figure 1 below. 
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Figure 1.  Flow of Participants through the Intervention 
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Participants 
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Intervention 
Participants who 
completed 
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18)   
Traditional 
Health Education 
using Didactics 
(n=25) 
1 Month 
Intervention 
Participants who 
completed 
treatment (n = 17) 
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Table 4 
Frequency Table of Participant Dropout by Type of Non-Completer Status 
  
Participants who Entered 
Website 
 
 
Participants who Did not Enter 
Website 
 
Participants who Completed 
Post-assessment 
 
 
35 
 
 
11 
 
Participants who did not 
Complete Post-assessment 
 
 
2 
 
 
5 
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Table 5 
Pre-intervention Comparison of Treatment Completers and Treatment Non-Completers 
 
Variable 
 
Treatment 
Completers    
(n = 35)  
 
Treatment Non-
Completers       
(n = 18) 
 
 
F or χ2 
 
P Value 
 
Caregiver Age (M, SD) 
 
53.49 (9.53) 
 
53.33 (10.80) 
 
.06 
 
.81 
 
Caregiver Years of Education 
 (M, SD) 
 
16.14 (2.61) 
 
15.78 (2.13) 
 
.10 
 
.75 
 
Caregiver DASS 21 score (M, SD) 
    
     Depression 4.37 (4.47) 5.78 (3.70) .00 .99 
     Anxiety 2.49 (3.01) 3.56 (3.48) .57 .45 
     Stress 6.51 (4.33) 8.67 (5.02) .99 .32 
 
Total Time as Caregiver in years 
(M, SD) 
 
3.69 (2.29) 
 
3.13 (2.66) 
 
.05 
 
.82 
 
Percent of Total Care Provided by 
Caregiver (M, SD) 
 
72.43 (30.04) 
 
72.00 (27.76) 
 
.54 
 
 
.67 
 
Caregiver Hassles: Information 
Seeking Subscale (M, SD) 
 
11.06 (8.88) 
 
12.56 (8.49) 
 
 
.71 
 
.40 
 
Caregiver Hassles: Scheduling 
Logistics Subscale (M, SD) 
 
9.97 (8.07) 
 
10.22 (7.25) 
 
1.80 
 
.19 
 
Caregiver Hassles: Safety Subscale 
(M, SD) 
 
5.89 (5.62) 
 
6.06 (5.03) 
 
.83 
 
.37 
 
Caregiver Hassles: Polypharmacy 
Subscale (M, SD) 
 
4.62 (4.31) 
 
4.72 (2.74) 
 
10.10 
 
.00** 
 
Caregiver Hassles: Total (M, SD) 
 
31.54 (24.31) 
 
33.56 (18.99) 
 
4.27 
 
.04* 
 
Self-Efficacy for Controlling 
Upsetting Thoughts: Total (M, SD) 
 
61.72 (30.78) 
 
63.69 (29.80) 
 
.12 
 
.73 
 
Caregiver Morisky Medication 
Adherence (M, SD) 
 
2.40 (1.38) 
 
2.56 (2.03) 
 
5.80 
 
.02* 
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Care-recipient HBLQ Score  
(M, SD) 
4.11 (1.23) 3.39 (1.50) 2.31 .14 
 
Care-Recipient CDR score  
(M, SD) 
 
1.59 (.90) 
 
1.19 (.46) 
 
18.51 
 
.00** 
 
Care-Recipient IADL score 
(M, SD) 
 
.94 (1.28) 
 
1.28 (1.67) 
 
1.09 
 
.30 
 
Care- Recipient ADL score  
(M, SD) 
 
2.68 (2.58) 
 
3.67 (2.14) 
 
4.04 
 
.05* 
 
Caregiver Ethnicity, n (%) 
   
1.17 
 
.76 
     Caucasian 25 (71.43%) 15 (83.33%)   
     African American 6 (17.14%0 2 (11.11%)   
     Latina 1 (2.85%) 0   
     Multiracial 3 (8.58%) 1 (5.56%)   
 
Relationship to Care Recipient n % 
   
4.62 
 
.33 
     Daughter 32 (91.43%) 15 (83.33%)   
     Granddaughter 1 (2.86%) 2 (11.11%)   
     Aunt/ Uncle 0 1 (5.55%)   
     Close Friend 2 (5.71%) 0   
 
Caregiver Income, n (%) 
   
9.71 
 
.46 
     Less than $5000 0 0   
     $5,000 - $9,999 0 0   
     $10,000  $14,999 1 (2.86%) 2 (11.11%)   
     $15,000 - $19,999 1 (2.86%) 2 (11.11%)   
     $20,000 - $20,999 4 (11.43%) 0   
     $30,000 - $39,999 5 (14.28%) 3 (16.67%)   
     $40,000 - $49,000 4 (11.43%) 2 (11.11%)   
     $50,000 - $59,000 4 (11.43%) 1 (5.56%)   
     $60,000 - $69,999 4 (11.43%) 0   
     Over $70,000 12 (34.28%) 8 (44.44%)   
 
Caregiver Employment Status, n 
(%) 
   
6.01 
 
.11 
    Retired 5 (14.29%) 5 (27.78%)   
     Working Full Time 18 (51.43%) 7 (38.89%)   
     Working Part Time 2 (5.71%) 4 (22.22%)   
     Unemployed 10 (28.57%) 2 (11.11%) 
 
  
* = p < .05, ** = p < .001 
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Procedures 
Women who responded to advertised information about the project, or who directly 
obtained the screening assessment link through the aforementioned sources, were directed to an 
online screener.  Before completing the online screening assessment, participants were asked to 
provide informed consent for the study.  The consent form emphasized participation as voluntary 
and explained that participation could be withdrawn at any time without prejudice to the person 
or the care recipient. Participants were offered a $25 gift card for each of their 2 completed 
online assessments (intake and post-intervention). This project was reviewed by the University 
of Missouri-St. Louis IRB, with approval given before initiating data collection. 
 Those who met study criteria and provide informed consent for the study, and who 
agreed to be enrolled in the intervention, were then sent an email containing the link to complete 
the pre-intervention assessment, and were entered into a study tracking log to monitor 
completion dates for assessments and timeline for further contacts.  In order to reduce survey 
fatigue, the initial assessment was broken into four smaller surveys so that participants could 
complete them across multiple sittings.  Participants were given one week to complete these 
surveys, after which they were sent a reminder email to finish the pre-intervention assessment.  
Average time to complete the pre-assessment was one week, with zero reminders. 
After completion of the pre-intervention assessment, participants were randomly assigned 
to one of the two treatment conditions, the narrative vignette treatment program or the 
comparison didactic condition.  Block randomization occurred after the pre-intervention 
assessment as the present study was part of a larger experiment that included both dementia and 
non-dementia caregivers.  Thus, in order to separate these types of caregiver into two groups, and 
evenly balance those in the control and experimental conditions, the project coordinator was 
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required to view care-recipient dementia status in the pre-assessment.  Although random 
assignment was not blind to project coordinator, this individual was required to access only one 
of the four initial surveys in order to determine the care-recipient’s dementia status.  Of note, all 
intervention materials and contact points were pre-determined and thus there was not possibility 
of differing participant assignment based on project coordinator knowledge of intervention 
condition. 
To ensure true random assignment, participants were given an ID number in ascending 
order as they entered the study.  An online random number generator was used to evenly divide 
ID numbers into two groups (narrative and didactic) before the study began.  A lab member, 
unaffiliated with the project, placed the randomly assigned condition type into sealed envelopes 
with the ID number on the front.  Once an individual was determined to be in the dementia 
group, the envelope with the correct participant number in the group was opened, and the 
individual was placed in the condition identified inside the envelope.  
Once randomized by condition, individuals were sent “Email 1,” which contained 
instructions for using the website as well as a login ID and password. On a weekly schedule, 
thereafter, participants were given access to new website materials via internal website stepped 
programing.  Using this same weekly schedule, participants were emailed and notified that their 
access level had been increased, and that they could view more materials. After four total weeks 
viewing materials, participants were sent the link to the online post-intervention assessment.  
Once again, to reduce fatigue, these interventions were broken into four smaller pieces.  All 
email contacts throughout the study were standardized – they were identical between groups, 
with the exception of brief details provided about the intervention in “Email 2” (e.g. describing 
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what participants would see when they entered the website).  See Appendix A to review of the 
email contact and website access timelines. 
   In order to ensure the quality of online data collected, steps were taken to guarantee that 
participants were providing thoughtful responses.  The length of time a participant took to fill out 
each assessment was measured and compared to median response times of other participants as 
well as time taken by pilot participants and project research assistants, to complete the measures.  
Those who completed the surveys in significantly less time than other participants would not be 
included in data-analysis in order to protect the quality of data.  The average time it took 
participants to complete the pre-assessment and post-assessment was approximately 60 minutes 
and 45 minutes, respectively.  The average time it took pilot participants and project research 
assistants to complete the pre-assessment and post-assessment, was 40 minutes and 30 minutes, 
respectively.  No participants took less than 30 minutes to complete the pre or post-intervention 
assessment, and thus, no participants were excluded based on this quality management, time-
based criteria. 
Experimental Conditions 
 Four health education areas, described in detail below, were developed to address 
specific caregiving concerns related to managing medications for an older adult.  All four content 
areas were included in both treatment conditions.  Throughout this study, both groups viewed the 
same online interface – a website entry page with four clickable content areas.  During the four 
weeks of their participation, all participants were sent weekly emails to notify them that their 
access level to the website had been increased. Each participant was assigned a week 1, week 2, 
week 3 and week 4 pre-programed access level, that was increased by the project coordinator at 
the start of that week. So, with each passing week in the intervention study, information was 
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added, but never taken away.        
 Although the two interventions were identical in the type of information and suggestions 
provided, they varied significantly in the presentation of the material.  In both groups, week 1-4 
access levels contained identical didactic handouts across condition, but additional narrative 
video vignettes were only included in the experimental narrative vignette treatment.  All 
participants were free to choose which branches to view and how much time to spend with the 
material throughout the intervention period.   
Comparison didactic group.  Participants entering the comparison didactic condition 
website first encountered a still screen shot with four clickable content areas.  When participants 
entered any content area, they saw another screen containing one column.  This column was 
titled “resources” and contained PDF didactic handouts with information about that content area, 
and a single video of an “expert” (pharmacist, nurse, psychologist or social worker) providing 
brief supplementary information.  All material available for a given week appeared as white 
clickable links; materials that were to become available in following weeks were grey and visible 
but not yet clickable as a link.  Materials from previous weeks remained available as participants 
progressed through the intervention.  
Narrative vignette condition. Participants entering the experimental condition’s website 
also encountered a still screen shot with four clickable content areas.  In the center of the page, 
they saw a clickable section titled “introduction.”  Upon clicking the introduction link, a video 
appeared, introducing the main narrator of the video vignettes.  This actor also briefly described 
the types of information that one would expect to see in the coming weeks.  When participants 
entered any content area, they saw another screen containing two columns.  As with the 
comparison condition, one column was titled “resources” and contained PDF didactic handouts 
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with information about that content area, and a single video of an “expert” (pharmacist, nurse, 
psychologist or social worker) providing brief supplementary information. 
The narrative vignette condition also included a second column, not present in the control 
condition, titled “Story.”  This column included brief video episodes, each less than four minutes 
in length, showing ethnically diverse care dyads encountering various medication related 
challenges as the weeks progressed.  Caregivers were directed to the PDF handouts to review 
methods for solving the concerns faced by dyads in the videos.  A new episode and a new set of 
handouts were available to the caregivers each week.  Basic medication management information 
and suggestions were interspersed throughout these video narratives; the vignettes were designed 
for “real life” relevance to caregiving experiences. The episodes began by demonstrating 
problem solving in “easy” scenarios and progressed in a graduated manner to more difficult 
problem solving scenarios, as is suggested by Bandura’s framework for building self-efficacy.  
All content in these videos was taken directly from content in the PDF handouts available in both 
conditions.  The material available for a given week appeared as white clickable links; materials 
that were to become available in following weeks were grey and visible but not yet clickable as a 
link.  Materials from previous weeks remained available as participants progressed through the 
intervention.  See Appendix B for a summary of resources available in each content area, over 
time.   
Health Education Content Areas across Conditions  
Managing medications.  This content area included a discussion of adverse events 
linked to medications (e.g., falls, delirium, nursing home placement, negative health outcomes), 
and provided information about the most effective ways to manage scheduling of doses and 
refills. This module also included psychoeducation about the role a pharmacist can play in 
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medication management problem solving, as well as a list of basic and advanced questions that 
can be used to help improve medication management and organizational skills.  The module 
provided further information about the benefits of assessing interaction effects of over-the-
counter medications with prescriptions that the care-recipient already takes; pharmacy staff 
consultation was highly encouraged. 
Talking together.  This content area focused on developing communication skills between 
the caregiver and care-recipient.  Caregivers were given instruction on how to use basic 
communication strategies such as eye contact, tone, and “I” language in everyday medication 
management interactions.  This content area also provided examples of medication-related 
conflict between the caregiver and care recipient, and provided suggestions for effective 
communication strategies when negotiating these disagreements. In addition, caregivers were 
encouraged to use these communication skills to think about the future with their older loved 
one, and were given resources on housing, financial planning, driving and healthcare plans as 
they may relate to an older loved one’s physical health conditions.  This module also addressed 
legal and HIPAA requirements for full communication between family members and healthcare 
professionals.  
Signs of confusion.  Given that caregivers of persons with thinking problems may not know 
the strengths and weaknesses of their loved one’s thinking abilities, as they pertain to medication 
management, this content area provided participants with information about the signs and 
symptoms of delirium and dementia, as well as ways to distinguish the two.  Caregivers were 
given information about the high rates of undiagnosed delirium and dementia in community 
dwelling older adults and the benefits of medical evaluation and diagnosis. Further information 
was presented about the process for obtaining a diagnosis for a progressively dementing 
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neurocognitive illness, including material about brief cognitive screens and neuropsychological 
testing, as well as the domains of thinking measured in these evaluations. 
Healthcare visits.  This content area provided caregivers with information about how to 
prepare for healthcare visits that they attend with their loved one.  Caregivers were given a list of 
example questions they could ask the medical providers about current medications, newly 
prescribed medications, over the counter medications, and side-effects. This module also 
addresses legal and HIPAA barriers to full communication between family members and 
healthcare professionals. The content area explained the need for signed releases on file in the 
patient’s chart to allow these conversations and provided an example of a nationally-available 
form for durable power of attorney for healthcare (Five Wishes).   
Measures  
At intake and post intervention (four weeks later), caregivers completed the following 
assessments. All measures were present at both time points, with the exception of the 
demographic questions, which were only assessed at pre-intervention, and self-reported 
satisfaction with the intervention, which was only assessed in the post-intervention assessment. 
Primary outcome measures. 
User Satisfaction regarding the Use of the Computer Program Questionnaire 
(USUCPQ).  This User Satisfaction Questionnaire (Ponpaipan et al., 2010) is an 8-item measure 
that assess user satisfaction with online health-based interventions. This measure is based on a 7-
point Likert scale (0 = Very Unsatisfied, 7 = Very Satisfied), with higher scores indicating 
greater levels of satisfaction.   The original scale was first utilized in a population of middle aged 
Taiwanese caregivers, to explore their satisfaction with an online study to promote increased 
exercise and healthful eating among their older loved ones.  Although this original study reported 
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good distribution in the data (N = 26 caregivers), no further psychometrics were reported.  This 
scale was selected due to its similarity in user population and function in assessing caregiver 
satisfaction with an online health based intervention.  The measure explored the following 
domains of caregiver satisfaction regarding the intervention a) convenience b) entertainment c) 
how interesting the content was d) speed of the modules e) usefulness f) practicality g) 
tolerability and h) how much information was presented. There are no subscales for this measure, 
rather a maximum of 56 points can be obtained, creating a total satisfaction score. This 8-item 
scale demonstrated excellent internal consistency in the current study (α =.96).   Results revealed 
that the USUCPQ was kurtotic and slightly negatively skewed (Table 6). One univariate outlier 
was identified on this measure, within the experimental treatment condition (z > 3.29).  This 
individual was not removed from analyses due to the small sample size.  Instead, mean value 
substitution was utilized to replace the individual’s satisfaction score.  No transformation was 
completed to allow for greater interpretability of the main analyses. 
The Family Caregiver Medication Administration Hassles Scale.  This measure consists 
of 24 items that reflect concerns over keeping prescription medications filled, scheduling 
logistics, safety issues, and information seeking (Travis et al., 2003).  Higher scores on this 
measure indicate greater levels of perceived hassle.  It is a self-reported instrument with four 
subscales.  The first subscale, Information Seeking/ Information Sharing, is comprised of 9 items 
that describe education and communication based hassles.  The second subscale, Scheduling and 
Logistics, contains 7 items and asks about medication management and administration hassles. 
The 5-item Safety Issues subscale asks about medication errors and adverse drug effects, while 
the 3-item Polypharmacy subscale measures hassles related to interactions with multiple 
prescribing providers and managing tasks related to multiple medications.  Caregivers are 
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instructed to rate each of the items on a scale from 0 = “not a hassle” to 5 = “one of the worst of 
all hassles.”  Scoring is completed by creating a total summed score of all items and total 
summed scores for the subscales.  The overall reliability of this instrument in initial 
psychometric studies α = 0.95, with subscale reliabilities of the following: Information 
Seeking/Information Sharing (α = .92), Safety Issues (α = .83), Scheduling Logistics (α =.90), 
and Polypharmacy (α =.80).  Test retest reliability was .84.    The overall reliability of this 
instrument was excellent in the current study (α = .97), similar to the scale’s original findings.   
The hassle subscales had the following internal reliability scores: Information 
Seeking/Information Sharing (α = .92), Safety Issues (α = .89), Scheduling Logistics (α =.86), 
and Polypharmacy (α =.83).  As seen in Table 6, the safety issues subscale was slightly 
positively skewed.  All other subscales and totals were within normal limits for measures of 
normality.  As such, no transformations were completed.  There was no evidence of outliers on 
this measure. 
Morisky Medication Adherence Scale.   This is an 8-item self-report measure that 
describes the medication adherence patterns in a given individual.   These items require “yes” or 
“no” self-reported responses, where a “yes” response is scored as a one, indicating a non-
adherent behavior, and a no is scored as a zero, indicating good medication adherence.  Higher 
scores on this measure, indicate poorer medication adherence.  Individuals with summed scores 
of 0 fall in the “high adherence” range, those with a 1-2 fall in the “medium adherence” range 
and those who score greater than 2 fall in the “low adherence” range.  This measure has been 
developed and evaluated for use with low-literacy patients, and has been reported as 
demonstrating high criterion validity with medication monitoring devices (Morisky et al., 2008).  
In the original literature, this measure demonstrates good internal reliability (α =.83).  In the 
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current study, this measure was modified such that the caregiver managing medications answer 
the questions about the care recipient’s level of adherence.  Present results show this measure 
was within the low range of acceptability for internal reliability (α =.60).  This measure 
demonstrated adequate response normality, with little kurtosis and skew (Table 6).  No outliers 
were identified and no transformations of the data were completed for responses on this 
instrument. 
Stanford Patient Communication with Physicians.  This measure consists of 3 self-
reported items that describe patient behaviors while speaking with a medical provider (Lorig et 
al., 1996).  The instrument instructs patients to rate each of their behaviors on a 5-point Likert 
scale from 0 = never to 5 = always.  A total score for this measure is obtained by computing the 
average of these three items.  Higher scores indicate better patient-provider communication.  The 
overall internal reliability of this instrument is 0.73, with test retest reliability at .89.    This 
instrument demonstrated good internal consistency in the current study (α = .70).   As seen in 
Table 6, the measure was within normal limits for kurtosis and skew.  As such, no 
transformations were completed.  Similarly, there was no evidence of outliers on this measure, 
and no data points were removed. 
Revised Scale for Caregiving Self-Efficacy: Self Efficacy for Controlling Upsetting 
Thoughts.  The Revised Scale for Caregiving Self-Efficacy is a 5-item instrument that asks 
caregivers to report their overall confidence from 0% to 100% in successfully controlling 
upsetting thoughts related to their caregiving situations (Steffen et al., 2002).  A 0% confidence 
indicates that they believed they could not do the specified task under any circumstances, 50% 
confidence indicates that if they gave it their best effort, chances are about 50-50 that they could 
perform the activity, and a 100% confidence indicates that they are certain they can perform the 
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given task.  Upsetting thoughts include thinking about unpleasant aspects of the caregiving 
situation, viewing the caregiving situation as unfair, thinking about how much they have lost, 
thinking about how much they are missing/giving up, and worrying about future problems.  
Internal reliability for this measure is good (α = .80) and test-retest reliability has been shown to 
be adequate (r = .76).  The internal consistence of this measure, within the current study, was 
excellent (α = .96).  Skew and Kurtosis in this sample were within normal limits, indicating 
acceptable normality of the data.  One multivariate outlier was identified within the experimental 
group; mean values of self-efficacy for controlling upsetting thoughts were substituted for this 
participant’s responses, in order to maintain the highest possible sample size.  
Covariate and demographic measures: Caregivers 
Caregiver demographics.  For descriptive purposes, caregivers provided information 
about their age, ethnicity, marital status, household income, level of education and employment 
outside of the home.  They were also required to provide information about their relationship to 
the care recipient, the number of years they have been caregiving, the amount of the care 
recipient’s total care that they personally provide, as well as the specific ways in which they help 
the older adult manage medications. 
Depression Anxiety Stress Scale (DASS) – 21 item short form.  The Depression Anxiety 
Stress Scale - 21, is a 21-item measure that asks participants to describe their current level of 
distress within the domains of depression, anxiety and stress (Lovibond & Lovibond, 1995).  
Responses are scored on a 4-point Likert scale where 0 = Never and 3 = Almost Always. Higher 
total scores in each domain, represent greater levels of subjective distress. The measure is broken 
into three domains of function, Depression, Anxiety and Stress, which each contain 7 items.  
Each subscale is calculated by summing the responses in that domain; cutoff score descriptions 
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within each field range from normal, to extremely severe, with total possible scores on each 
subscale ranging from 0-21.  This scale has demonstrates good internal reliability; Depression α 
= .94, Anxiety α = .87 and Stress α = .91.  The DASS has also been shown to have good 
convergent validity with other measures of depression and anxiety (BAI and BDI), and is 
psychometrically sound across multiple populations both clinically and non-clinically based 
(Antony, Bielig, Cox, Enns, & Swinson, 1998; Lovibond & Lovibond, 1995).  In the current 
study, the DASS-21 demonstrated good to excellent levels of internal consistency: Depression α 
= .92, Anxiety α = .80 and Stress α = .90.  Additionally, results revealed that the Depression 
Subscale of the DASS was slightly positively skewed and kurtotic, while the Stress scale was 
slightly positively kurtotic (Table 6). There was no evidence of outliers. No transformations were 
completed to allow for greater interpretability of the main analyses. 
Intervention Dosage: Login Access.  The intervention website included an 
administrative option that tracked the number of times an individual caregiver logged into the 
site using their unique login ID and password.  Using the “Slimstats” function within the 
administrative access portion of the website, the total number of logins was found for each 
individual participant.  Only those caregivers who had logged into the intervention website, a 
minimum of one time, were included in final analyses as treatment completers.  Those who never 
logged into the intervention website were considered treatment non-completers. 
Intervention Dosage: Didactic Resource Access.  The intervention website also tracked 
whether or not an individual downloaded a handout or didactic video, how many times this 
occurred, and at what time.  Each PDF handout and didactic video was reviewed for usage 
statistics and tied to an individual participant, using the “slimstats” function within the 
administrative access portion of the website. The total number of times an individual 
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downloaded each type of resource was summed.  Thus, an individual could view a single PDF or 
didactic video multiple times, and each occurrence was counted as a discrete event for that 
resource.  These viewing events were then summed within the four content areas to describe the 
number of resource downloads/ views within the domains of “Medication Management,” 
“Talking Together,” “Signs of Confusion, “ and “Healthcare Visits.” 
 Intervention Dosage: Narrative Video Access.  Similar to the aforementioned usage 
measures, the intervention website tracked whether or not an individual in the experimental 
condition downloaded a narrative video, how many times this occurred, and when.  Each 
narrative video was reviewed for usage statistics and tied to an individual participant, using the 
“Slimstats” function within the administrative access portion of the website. The total number of 
times an individual downloaded each type of video was summed.  Each viewing occurrence was 
counted as a discrete event for that video resource.  These viewing events were then summed 
within the four content areas to describe the number of episode views within the domains of 
“Medication Management,” “Talking Together,” “Signs of Confusion, “ and “Healthcare Visits.” 
Covariate and demographic measures: Care recipients 
Care recipient demographics.  Caregivers were asked to provide several pieces of 
information about the older adult for whom they provide care.  Caregivers described the care 
recipient’s current living arrangements, race/ethnicity, category of neurocognitive diagnosis and 
were asked to check boxes with medical diagnostic categories that matched the concerns of their 
care-recipient.  Caregivers also reported the total number of prescription medications that their 
care-recipient was prescribed, as well as the total number of over-the-counter medications this 
individual utilized.  Participants were not asked about the function of these medications, specific 
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names of the medications or dosages, in order to preserve care-recipient confidentiality for care-
recipient protected health information. 
HbLq Medication Risk Questionnaire.  This 8- item measure is designed to assess 
medication regimen complexity as well as risk for adverse drug events in older adults (ADEs).  
Individuals are asked to report on various aspects of medication complexity and risk, by 
selecting a “yes” or “no” response for each of the 8 risk factors for an ADE.  A “yes” response is 
coded as a one, while a “no” is coded as a zero.  Item scores are summed to create an overall 
medication complexity and risk score, with higher numbers indicating greater risk.   The scale 
contains questions regarding number of medications, number of prescribing physicians, number 
of medical problems and pharmacies (Levy, 2003).  This scale demonstrates adequate internal 
consistency in original psychometrics studies (α = .69), with high test-restest reliability (κ > 0.6).  
The current study demonstrates similar levels of internal consistence (α = .70) and is normally 
distributed with minimal kurtosis and skew (Table 6).  No outliers were identified and no 
transformations were made based on the already normally distributed nature of the data. 
Analogue Clinical Dementia Rating Scale (CDR).  This measure was originally 
developed as a structured clinical interview. The analogue CDR is scored on a five-point scale 
that is meant to describe individuals without neurocognitive concerns (0) and with questionable 
(0.5), mild (1), moderate (2), and severe (3) neurocognitive difficulties. The overall CDR score is 
determined by a complex algorithm that takes into account items in six domains of functioning: 
memory, orientation, judgment and problem solving, involvement in community affairs, 
involvement at home and in hobbies, and personal care. In its original format, clinicians score 
each domain of functioning, and are instructed to score each functional domain independently 
from the others.  Original levels of inter-rater reliability for this measure were high, with all 
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domains ranging from .75 - .94.  This scale was modified for the current study: all items were 
given with the exact same instructions, but the caregivers were asked to rate their own 
perceptions of the care-recipient’s level of impairment. Internal reliability of the measure 
administered in this new format for the current study, was excellent (α = .93).  Responses on this 
measure demonstrated a normal distribution with minimal kurtosis and skew (Table 6).  No 
outliers were identified.  As such, no transformations were made to the data and no data points 
were removed. 
Activities of Daily Living Form. Caregivers were asked to report on the current 
functional deficits of the identified family member, using the Katz Activities of Daily Living 
Form (ADL; Katz et al., 1963).  This questionnaire asks caregivers whether care-recipients are 
able to independently bathe, eat, toilette etc.  Scores on this measure range from 0 to 6 with 0 
being the highest level of impairment in ADLs (ADL; Katz, Ford, Moskowitz, Jackson, & Jaffee, 
1963). This instrument was originally designed to be rated by a healthcare professionals but has 
since been shown to be reliable (α = .78-.94) and valid when completed by family caregivers 
(Sikkes, et al., 2010).  This measure demonstrated excellent internal reliability in the current 
study (α = .91), but was negatively skewed (Table 6).  No outliers were identified and to 
maintain interpretability of the results, no transformations of the data were completed. 
Independent Activities of Daily Living. Caregivers were asked to report on their care-
recipient’s ability to perform independent activities of daily living as measured by the 
Independent Activities of Daily Living Scale (IADL; Lawton, Moss, Fulcomer & Kleban, 1982).  
This is a 31 item measure which assesses 8 domains of functioning: Ability to use the telephone, 
shopping, food preparation, housekeeping, laundering, obtaining transportation, responsibility 
for own medications and finances. Scores on this measure range from 0 to 8, with a score of 0 
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indicating the greatest level of impairment.  This instrument was originally designed to be rated 
by a healthcare professionals but has since been shown to be reliable (α = .78-.90) and valid 
when completed by family caregivers (Sikkes, et al., 2010).  This measure demonstrated 
acceptable levels of internal reliability in the current study (α = .64), but was positively skewed 
and kurtotic (Table 6).  No outliers were identified and to maintain interpretability of the results, 
no transformations of the data were completed. 
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Table 6 
Psychometric Properties of Study Variables (n = 35 User Satisfaction; N =53 other Variables) 
 
Variable 
 
Mean 
 
SD 
 
Range 
 
SE of 
Skew 
 
Skew 
 
SE of 
Kurtosis 
 
Kurtosis 
 
alpha 
 
User Satisfaction 
 
43.97 
 
9.50 
 
8-56 
 
.40 
 
-1.80 
 
.78 
 
4.90 
 
.96 
 
Medication 
Administration Hassles  
 
 
32.22 
 
 
22.48 
 
 
0-90 
 
 
.33 
 
 
.67 
 
 
.64 
 
 
-.21 
 
 
.97 
     Subscale: 
     Information Seeking 
 
11.57 
 
8.70 
 
0-34 
 
.33 
 
.64 
 
.64 
 
-.12 
 
.92 
     Subscale: 
     Safety Issues 
 
5.94 
 
5.38 
 
0-22 
 
.33 
 
1.02 
 
.64 
 
.65 
 
.89 
     Subscale: 
     Scheduling Logistics 
 
10.06 
 
7.32 
 
0-27 
 
.33 
 
.44 
 
.64 
 
-.72 
 
.86 
     Subscale: 
     Polypharmacy 
 
4.66 
 
3.83 
 
0-13 
 
.33 
 
.67 
 
.64 
 
-.86 
 
.83 
 
Morisky Medication 
Adherence Scale 
 
2.45 
 
1.61 
 
0-7 
 
.33 
 
.65 
 
.64 
 
-.06 
 
.60 
 
Stanford Patient 
Communication Scale 
 
3.24 
 
1.81 
 
0-5 
 
.33 
 
-.73 
 
.64 
 
.50 
 
.70 
 
Self-Efficacy For 
Controlling Upsetting 
Thoughts 
 
 
62.35 
 
30.18 
 
0-100 
 
.33 
 
-.49 
 
.64 
 
-.95 
 
.96 
DASS: Depression 4.85 4.25 0-21 .33 1.32 .64 2.67 .92 
DASS: Anxiety 2.89 3.12 0-11 .33 .99 .64 -.01 .80 
DASS: Stress 7.24 4.64 0-21 .33 .98 .64 1.13 .90 
 
Medication Risk HBLQ 
 
3.87 
 
.19 
 
1-7 
 
.33 
 
-.13 
 
.64 
 
-.41 
 
.70 
 
Clinical Dementia 
Rating Scale 
 
1.45 
 
.80 
 
.5-3 
 
.33 
 
.75 
 
.64 
 
-.58 
 
.93 
 
Activities of Daily 
Living 
 
3.02 
 
3.47 
 
0-6 
 
.33 
 
.01 
 
.64 
 
-.70 
 
.91 
 
Independent Activities 
of Daily Living 
 
 
1.06 
 
1.41 
 
0-6 
 
.33 
 
1.74 
 
.64 
 
2.80 
 
.64 
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Data Analytic Strategy 
Independent sample t-tests were used to evaluate between group differences in 
satisfaction with each treatment strategy, post-intervention.  A repeated measure MANOVA 
assessed Condition * Time effects and the main effect of time on participant self-reported 
hassles.  Similarly, repeated measure ANOVA analyses assessed Condition * Time effects and 
the main effect of time for the following dependent variables; patient-provider communication, 
medication adherence and self-efficacy for controlling upsetting thoughts. 
In order to achieve power of 0.80 for the primary analyses, at an alpha of .05, with a large 
effect size (d = .80), a minimum of 26 participants were required at pre and post-intervention, in 
each treatment group (Cohen, 1992). Thus, of the initially planned data analyses, the largest 
sample size necessary was N = 52.  This study is considered underpowered for testing mean 
differences in scores (N = 35), due to attrition of the initially enrolled 53 participants.  Because 
the analyses were not modified to accommodate this small sample size, Cohen’s d and p

were 
utilized in unison with p values to assess for statistical significant differences between groups 
scores.  Further, p value corrections for type one error were not utilized due to the underpowered 
nature of this study. 
No missing values were present in this data set.  All responses to primary measures in the 
pre-assessment and post-assessment were marked in the survey software as “required” items, due 
to the anticipated difficulty in obtaining participants who qualified for the study, as well as the 
potential dropout.  As described above, all data were screened for high quality of responses.  No 
participants were removed due to low response quality, as all individuals fell within the 
estimated highest on lowest time range of assessment completion. All data was checked for 
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normality; no transformations were completed in order to allow for ease of interpretability.  
Independent sample t-tests and chi square analyses were completed to assess for pre-treatment 
equivalence, as described above.  The narrative vignette and comparison didactic group were 
approximately equivalent on all initially gathered demographic variables, but the comparison 
didactic group began the intervention reporting a greater level of medication administration 
hassles.  In instances where outliers were identified, mean value substitution was utilized to 
replace outlying values.  Mean insertion based upon outlier data was infrequent and occurred in 
less than 3% of cases.   
Intervention Website Usage 
In order to describe website usage patterns, resource access statistics were downloaded 
and sorted by type of resource viewed (i.e. content area of resource) and the format of the 
resource viewed (narrative video or didactic resource).  Each participant’s resource usage was 
coded using the cumulative number of views for each individual didactic video and narrative 
resource, as opposed to a binary “viewed” or “not viewed” system.  All participants who logged 
into the intervention website, including those who did not complete assessment time point two, 
were included in website usage analyses (control n = 19; experimental n = 18).   
As shown in Table 7, when compared across treatment conditions, didactic comparison 
group caregivers and narrative vignette caregivers, viewed approximately equivalent numbers of 
didactic resources in the following intervention topic areas: “Medication Management,” “Talking 
Together,” and “Causes of Confusion.”   Caregivers in the narrative vignette group viewed a 
greater number of PDF and expert video resources within the “Healthcare Visits” content area 
than did comparison didactic group participants (didactic M = 1.84, SD = .2.17; narrative 
vignette M = 2.39, SD = 2.68; p = .04; Cohen’s d = .23).  A trend arose, but did not reach 
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significance, when comparing the total number of PDF and didactic video resources viewed 
between comparison didactic and narrative vignette group participants; narrative group 
participants showed a non-significant trend toward viewing a greater total number of didactic 
resources than the comparison didactic group (didactic M = 12.05, SD = 10.60; narrative M = 
14.22, SD = 13.21; p = .07; Cohen’s d = .19).  As described above, the PDF and expert video 
didactics were available in both conditions.  When caregivers were compared by treatment 
condition on their total usage of all resources, including both didactic resources and narrative 
video episodes (only available to the experimental group), caregivers in the experimental 
condition showed a greater number of total views for all website resources (didactic M = 12.31, 
SD = 10.99; narrative M = 27.00, SD = 23.64; p < .001; Cohen’s d = .83,) 
Caregiver narrative video usage was also examined for descriptive purposes.  As reported 
in Table 8, participants in the narrative vignette condition showed the highest number of 
narrative video views in the “medication management” content area (M = 3.44, SD = 3.20), 
followed by “Talking Together” (M = 2.89, SD = 2.87),  “Causes of Confusion” (M = 2.67; SD = 
2.81) and “Healthcare Visits” (M = 2.39, SD = 2.59). 
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Table 7 
Number of Didactic Resource Views (PDF + Didactic Video) and Total Resources Viewed (PDF 
+ Didactic Videos + Narrative Videos) per Content Area, across Conditions 
 
Variable 
 
Didactic       
( n = 19) 
 
Narrative    
(n = 18) 
 
 
F 
 
P Value 
 
Cohen’s d 
 
Number of Didactic Resource 
views; “Medication 
Management” (M , SD) 
 
 
3.00 (3.53) 
 
4.39 (4.31) 
 
 
.44 
 
.51 
 
.36 
 
Number of Didactic Resource 
Views; “Talking Together”   
(M , SD) 
 
 
3.00 (2.92) 
 
3.22 (3.51) 
 
 
2.32 
 
.14 
 
.07 
 
Number of Didactic Resource 
Views “Causes of Confusion” 
(M , SD) 
 
 
4.21 (3.43) 
 
4.22 (3.69) 
 
1.24 
 
.27 
 
0.0 
 Number of Didactic Resource 
Views; “Healthcare Visits”  
(M , SD) 
1.84 (2.17) 2.39 (2.68) 
 
 
4.78 .04* .23 
 
Total Didactic Resources 
Viewed (M , SD) 
 
 
12.05 (10.60) 
 
14.22 (13.21) 
 
3.61 
 
.07 
 
.19 
 
Total number of All Resources 
Viewed, Any Type (M , SD) 
 
 
12.31 (10.99) 
 
27.00 (23.64) 
 
17.46 
 
.00** 
 
.83 
* = p < .05., ** = p < .001 
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Table 8 
Description of Total Narrative Episode Viewing Incidents per Content Area 
 
Content Area 
 
M 
 
 
SD 
 
 “Medication Management” 
  
3.44 
 
3.20 
  
“Talking Together” 
 
2.89 
 
2.87 
 
 “Causes of Confusion” 
 
2.67 
 
2.81 
  
 “Healthcare Visits” 
 
 
2.39 
 
2.59 
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Results 
Primary Outcomes 
 Hypothesis one.  Independent samples t-tests were used to test the hypothesis that 
participants in the narrative vignette condition would report higher levels of satisfaction with the 
intervention than participants in the comparison didactic group.  As seen in Table 9, analyses 
revealed that there were no significant differences between the narrative vignette and comparison 
didactic condition on total intervention satisfaction scores (Control M = 45.33, SD = 7.81; 
Experimental M =44.68, SD = 6.75; p = .46, Observed power = .08).  Similarly, no significant 
differences were found between groups on satisfaction levels with the intervention’s level of 
convenience, level of  interest it provoked, pace, tolerability or amount of information that was 
presented.  Although non-significant, a trend emerged with narrative group participants reporting 
slightly higher levels of satisfaction with the intervention entertainment value (Control M = 5.11, 
SD = 1.28; Experimental M =5.19, SD = 1.09; p = .15, Observed power = .08) 
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Table 9 
Comparison of Participant Intervention Satisfaction across Treatment Conditions 
 
Variable 
 
Didactic        
( n = 18) 
 
 
Narrative   
(n = 17) 
 
F 
 
P 
Value 
 
Cohen’s 
d 
 
Power 
 
Satisfaction Total (M , SD) 
 
45.33 (7.81) 
 
44.68 (6.75) 
 
 
.56 
 
.46 
 
.09 
 
.08 
 
Satisfaction: Convenience 
(M , SD) 
 
 
5.94 (1.11) 
 
5.75 (1.00) 
 
 
.23 
 
.63 
 
.18 
 
.13 
 
Satisfaction: Entertainment 
(M , SD) 
 
 
5.11 (1.28) 
 
5.19 (1.09) 
 
2.17 
 
.15 
 
.07 
 
.08 
 
Satisfaction: Interesting  
(M , SD) 
 
 
5.50 (1.15) 
 
5.75 (.93) 
 
1.24 
 
.28 
 
.24 
 
.17 
 
Satisfaction: Fast (M , SD) 
 
 
5.71 (1.07) 
 
5.63 (1.09) 
 
.02 
 
.89 
 
.07 
 
.08 
 
Satisfaction: Useful  
(M , SD) 
 
 
5.67 (1.24) 
 
5.50 (1.10) 
 
.31 
 
.58 
 
.15 
 
.11 
 
Satisfaction: Practical  
(M , SD) 
 
 
5.94 (.94) 
 
5.56 (1.10) 
 
.86 
 
.36 
 
.37 
 
.28 
 
Satisfaction: Tolerable 
 (M , SD) 
 
 
5.72 (.90) 
 
5.60 (1.03) 
 
1.25 
 
.27 
 
.12 
 
.10 
 
Satisfaction: Information 
(M , SD) 
 
 
5.72 (1.45) 
 
5.75 (1.00) 
 
1.51 
 
.23 
 
.02 
 
.06 
* = p < .05. 
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 Hypothesis two.  A repeated measures two-group, Time * Condition MANOVA, was 
used to test the hypothesis that narrative vignette group participants would report greater 
decreases in medication management hassles than participants in the comparison didactic 
condition from pre-treatment to post-treatment (for variable means see Table 10). Results 
indicate that the composite dependent variable, comprised of the change in four hassles subscales 
from pre-treatment to post-treatment, was not significantly affected by treatment condition F (4, 
30) = 1.63, p = .19, p

 = .18, achieved power = .44 (Table 11). Intervention dosage, as 
measured by total number of discrete didactic and narrative resource viewing events, was 
examined as a covariate in this model, but was not retained.  Univariate analyses found non-
significant results across tested subscales associated with small portions of the variance in 
change: Hassles of Information Seeking F (1, 33) = .08, p = .78, p

 = .00, Observed Power = 
.06; Hassles of Scheduling F (1, 33) = 1.25, p = .27, p

 = .04, Observed power = .19; Hassles of 
Safety F (1, 33) = .01, p = .93, p

 = .00, Observed power = .05; Hassles of Polypharmacy F (1, 
33) = .3.66, p = .07, p

 = .11, Observed Power = .46.  Similarly, this analysis revealed a non-
significant main effect of time on caregiver reported medication administration hassles F (4, 30) 
= .89, p = .48, p

 = .11, achieved power = .25 (Table 11).  Based on these results, hypothesis 
two was not supported. 
Hypothesis three. A repeated measures two-group, Time * Condition ANOVA, was 
used to test the hypothesis that narrative vignette group participants would report a greater 
increase in positive patient – provider communication behaviors, than participants in the 
comparison didactic condition from pre-treatment to post-treatment. Results showed that 
caregiver communication behaviors, from pre-treatment to post-treatment, were not significantly 
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affected by treatment condition F (1, 33) = 2.74, p = .11, p

 = .08, Achieved power = .36 (Table 
11).  Based on initial group differences, the total medication administration hassles score was 
examined for inclusion in this model as a covariate, but was not retained as a significant 
covariate in the model.   Similarly, intervention dosage, as measured by total number of discrete 
didactic and narrative resource viewing events, was examined as a covariate in this model, but 
not retained. This analysis also revealed a non-significant main effect of time on patient-provider 
communication F (1, 33) = .22, p = .65, p

 = .01, Achieved power = .07 (Table 11).  Overall, 
there was no evidence to suggest that caregiver communication behavior was impacted 
differently by treatment condition over time.  Thus, hypothesis three was not supported. 
Hypothesis four.  A repeated measures two-group, Time * Condition ANOVA was used 
to test the hypothesis that narrative vignette group participants would report a greater 
improvement in medication adherence behaviors related to the care-recipients regimen, than 
participants in the comparison didactic condition from pre-treatment to post-treatment. Results 
showed that medication non-adherence, from pre-treatment to post-treatment, was not 
significantly affected by treatment condition F (1, 33) = 2.83, p = .10, p

 = .08, Achieved power 
= .37 (Table 11).  Based on initial group differences, pre-treatment total hassles score was 
examined for inclusion in this model as a covariate, but was not retained as significant.  
Similarly, intervention dosage, as measured by total number of discrete didactic and narrative 
resource viewing events, was examined as a covariate in this model, but was not retained.  
Overall, there was no evidence to suggest that caregiver adherence to prescribed regimens was 
impacted differently by treatment condition over time.  This analysis also revealed a non-
significant main effect of time on caregiver medication management F (1, 33) = .96, p = .34, p

 
= .03, Achieved power = .16  (Table 11).  As a result, hypothesis four was not supported. 
Medication Non-Adherence and Dementia  72 
 
Hypothesis five.  A repeated measures two-group, Time *Condition ANOVA was used 
to test the hypothesis that experimental treatment condition participants would report a greater 
increase in self-efficacy for controlling upsetting thoughts about the caregiving situation, than 
participants in the control didactic condition from pre-treatment to post-treatment. Results 
showed that self-efficacy for controlling upsetting thoughts, from pre-treatment to post-
treatment, was not significantly affected by treatment condition F (1, 33) = .09, p = .76, p

 = 
.00, Achieved power = .06.  Based on initial group differences, the total pre-treatment 
medication administration hassles score was examined for inclusion in this model as a covariate, 
but was not retained, due to non-significance.  Similarly, intervention dosage, as measured by 
total number of discrete didactic and narrative resource viewing events, was examined as a 
covariate in this model, but was not retained.  This analysis did, however, reveal a significant 
main effect of time on caregiver self-efficacy for controlling upsetting thoughts about the 
caregiving situation F (1, 33) = 8.07, p < .001, p

 = .20, Achieved power = .79.  Examination of 
pre/post-treatment means and standard deviations reveal this change occurred in the direction of 
improved self-efficacy for controlling upsetting thoughts over time. 
Hypothesis five exploratory analyses.  Due to the apparent increase in self-efficacy for 
controlling upsetting thoughts in both groups, over time, exploratory analyses were used to 
assess the significance of these within group changes, and to determine whether one or both 
groups was driving the significant result. Paired sample t-tests were computed to determine if 
there was a change in Self-Efficacy for Controlling Upsetting thoughts within comparison 
didactic group participants from pre-treatment to post treatment (Table 12).  Results indicate that 
the overall caregiver self-efficacy for controlling upsetting thoughts score did not change 
significantly within the didactic group between pre-treatment and post-treatment.  Although 
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participants in the comparison didactic condition show marginal increases in total levels of Self-
efficacy for controlling upsetting thoughts, as well as individual areas of self-efficacy (i.e., 
controlling thoughts about unpleasant aspects of care, fairness, their previous life, things they 
have given up and worries about the future), these changes did not reach statistical significance. 
Similarly, paired sample t-test were used to compare narrative vignette group participants 
on self-efficacy for controlling upsetting thoughts at pre-treatment and post-treatment (Table 13).  
Results indicate that caregiver self-efficacy improved significantly within the narrative vignette 
group from pre-treatment to post-treatment.  Caregivers in the narrative condition showed a 
significant overall increase in self-efficacy for controlling upsetting thoughts from pre-treatment 
(M =  62.95, SD = 33.55) to post treatment (M =  72.38, SD = 31.27), t(17) = -2.53, p =.02.  
Specifically, participants in the narrative condition significantly increased in their self-efficacy 
for controlling upsetting thoughts about unpleasant aspects of the caregiving situation (pre-
treatment M =  63.17, SD = 32.74; post treatment M =  72.47, SD = 31.71, t(17) = -2.18, p =.04; 
Cohen’s d = .30) thoughts about caregiving being unfair (pre-treatment M =  62.23, SD = 36.00; 
post treatment M =  73.11, SD = 33.95, t(17) = -2.11, p =.05; Cohen’s d = .32 ) and worries 
about the future (pre-treatment M =  53.59, SD = 33.76; post treatment M =  62.17, SD = 33.57, 
t(17) = -2.11, p =.05; Cohen’s d = .26).  Although it did not reach statistical significance, there 
was a trend toward improvement in controlling upsetting thoughts about the “how good life was 
before caregiving,” (pre-treatment M = 66.12, SD = 37.88; post treatment M =  75.56, SD = 
33.45, t(17) = -2.04, p =.06; Cohen’s d = .27).  Overall, caregivers in the experimental group 
demonstrated improved total self-efficacy for controlling upsetting thoughts, as well as improved 
self-efficacy for controlling upsetting thoughts in several individual domains. 
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Table 10 
Pre and Post-Intervention Scores on Primary Outcome Measures across Treatment Condition 
  
Didactic (n = 18) 
 
Narrative (n = 17) 
 
Variable 
 
 
Pre- Treatment 
 
Post- Treatment 
 
Pre-Treatment 
 
Post- Treatment 
Omnibus Test: 
Medication Hassles 
 
 
   
     Information    
     Seeking (M, SD) 
 
11.83 (10.06) 
 
10.83 (8.20) 
 
10.23 (7.67) 
 
13.00 (7.70) 
     Scheduling  
    (M, SD) 
 
10.83 (8.31) 
 
9.50 (7.09) 
 
9.06 (7.96) 
 
8.76 (8.68) 
    Safety (M, SD) 6.77 (6.57) 4.72  (4.10) 4.94  (4.39) 6.41 (4.03) 
    Polypharmacy  
    (M, SD) 
6.00 (4.77) 3.83 (4.16) 3.17 (3.32) 3.11 (3.52) 
 
Omnibus Test: Stanford 
Patient Communication 
Scale (M, SD) 
 
3.83 (.86) 
 
3.52 (1.15) 
 
2.90 (1.20) 
 
3.09 (1.40) 
 
Omnibus Test: Morisky 
Medication Adherence 
(M, SD) 
 
2.56 (1.65) 
 
2.11 (1.64) 
 
2.23 (1.03) 
 
2.35 (1.17) 
 
Omnibus Test: Self-
Efficacy for Controlling 
Upsetting Thoughts   
(M, SD) 
 
62.67 (27.21) 
 
70.28 (28.82) 
 
62.95 (33.55) 
 
72.38 (31.27) 
* = p < .05. 
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Table 11 
Repeated Measures Multivariate and Univariate Analysis of Variance for Primary Outcome 
Variables 
 
Variable 
 
 
df 
 
MS 
 
F 
 
p 

p

 
 
Observed 
Power 

Omnibus Test:  
Medication Hassles 
      
     Time  4 12.06 .89 .48 .11 .25 
     Condition * Time 4 35.11 1.63 .19 .18 .44 
 
Omnibus Test:  
Patient Communication 
      
     Time 1 .08 .22 .65 .01 .07 
     Condition * Time 1 1.06 2.74 .11 .08 .36 
 
Omnibus Test:  
Medication Adherence 
      
     Time 1 .47 .96 .34 .03 .16 
     Condition * Time 1 1.38 2.83 .10 .08 .37 
 
Omnibus Test: SECUT 
      
     Time 1 1268.49 8.07 .00** .20 .79 
     Condition *Time 
 
1 14.36 .09 .76 .00 .06 
Note: SECUT = Self Efficacy for Controlling Upsetting Thoughts.  * = p < .05; ** = p < .001. 
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Table 12 
Secondary Analyses: Within Subjects Comparison of Didactic Group Participants on Pre-
treatment and Post-treatment Self-Efficacy (n = 18) 
 Pre-Treatment Post-Treatment 
 
95% CI for 
Mean 
Difference 
 
 
 
 
 
 
  
 
Outcome M SD M 
 
SD 
 
 t df 
 
p 
Cohen’s 
d 
 
SECUT: Total 
 
62.67 27.21 70.28 28.82 -17.41, 2.18 -1.64 17 
 
.12 
 
.28 
     SECUT: 
     Unpleasant   
     Aspects of Care 
70.78 25.43 76.27 24.62 -18.16, 7.67 -.92 17 
 
.37 
 
.23 
     
     SECUT: Unfair 
 
68.00 
 
28.87 
 
74.67 
 
27.58 
 
-17.03, 3.73 
 
-.35 
 
17 
 
.19 
 
.24 
     
     SECUT:  
     Previous life 
61.78 31.78 69.27 34.20 -19.04, 4.03 -1.37 17 .19 .23 
      
     SECUT: Gave   
     up for care 
62.83 31.51 69.72 31.26 -18.71, 4.93 -1.23 17 .24 .23 
      
     SECUT:  
     Worries about 
     Future 
 
49.94 33.62 61.44 34.68 -26.79, 3.79 -1.56 17 
 
 
.13 
 
 
.35 
Note.   SECUT = Self- Efficacy for Controlling Upsetting Thoughts, * = p < .05 
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Table 13 
Secondary Analyses: Within Subjects Comparison of Narrative Group Participants on Pre-
treatment and Post-treatment Self-Efficacy (n = 17) 
 Pre-Treatment Post-Treatment 
 
95% CI Mean 
Difference 
 
  
  
 
Outcome 
 
M SD M SD  t df 
 
p 
Cohen’s 
d 
 
SECUT: Total 
 
62.95 
 
33.55 72.38 31.27 -17.32, -1.52 -2.53 16 .02* 
 
.30 
     SECUT: 
     Unpleasant   
     Aspects 
63.17 32.74 72.47 32.71 -18.34, -.241 -2.18 16 .04* 
 
.36 
      
    SECUT:          
     Unfair 
62.23 36.00 73.11 33.95 -19.81, .05 -2.11 16 .05* 
 
.32 
      
     SECUT:  
     Previous life 
66.12 37.88 75.76 33.45 -19.68, .04 -2.04 16 .06 
 
.27 
     
     SECUT: Gave   
     up for care 
61.64 36.97 68.71 35.86 -15.99, 1.87 -1.68 16 .11 
 
.23 
      
     SECUT:  
     Worries about 
     Future 
 
53.59 33.76 62.17 33.57 -17.22, 04 -2.11 16 .05* 
 
 
.26 
Note.   SECUT = Self- Efficacy for Controlling Upsetting Thoughts, * = p < .05 
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Discussion 
Summary of Results 
 This study assessed the efficacy of two differing online health education interventions. 
Both conditions were designed to improve medication management and related healthcare 
behaviors in informal caregivers of older persons with dementia.  The didactic comparison 
condition contained a series of downloadable PDF “Handouts” with information about managing 
medications, attending a healthcare visit, causes of confusion in older adults, and communication 
with the older loved ones.  Each section included one video of an expert providing information in 
traditional didactic voice.  The narrative vignette condition included the same content as above, 
with additional web episode storylines that showed caregivers interacting with their loved one, 
and problem solving concerns in each of the aforementioned domains.  The current study 
introduced one of very few health oriented interventions targeting informal dementia caregivers 
(George & Steffen, 2015; Kamimura, Ishiwata & Inoue, 2012).     
 Although this study presented with challenges, such as limited sample size and 
correspondingly low power, several significant findings emerged in the data.  Firstly, caregivers 
in the narrative vignette condition showed more thorough usage of materials on the intervention 
website than those in the didactic condition.  Participants in the narrative condition viewed more 
didactic resources (PDF + expert video) in the area of “Healthcare Visits,” than the comparison 
didactic group.  Although there were more total resources available in the experimental group, 
the data suggests that caregivers in this condition fully utilized this additional information; 
narrative group participants viewed more available links, in total, than those in the comparison 
didactic group.  Finally, a non-significant trend emerged, suggesting that caregivers in the 
narrative condition might view more didactic resources, overall, than individuals in the 
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comparison condition.          
 Primary analyses revealed that there were no significant differences between the narrative 
vignette and comparison didactic groups on their reported levels of satisfaction with the 
intervention, after treatment was completed.  In addition, there were no Time * Condition effects 
on medication hassles, communication with healthcare providers, medication management 
adherence, or self-efficacy for controlling upsetting thoughts.  Analyses revealed a significant 
main effect of time on self-efficacy for controlling upsetting, across condition.  Nevertheless, the 
primary hypotheses were not supported.        
 Secondary analysis for this study revealed a number of significant results.  Within group 
comparisons of narrative vignette participants showed that this group improved significantly in 
their self-efficacy for controlling upsetting thoughts about the caregiving situation from pre-
intervention to post-intervention.  Although trends existed, comparison didactic group 
participants did not see the same significant within-group gains on self-efficacy, over time.  
These points are considered below, in detail, and the study is reviewed for current strengths, 
limitations and future directions. 
Sample Description 
 This sample of caregivers was comprised of predominately Caucasian, middle-aged 
women, caring for a parent who was diagnosed with Alzheimer’s disease.  Of note, 
approximately 38% of caregivers knew that their loved one was diagnosed with a dementing 
illness, but did not know the exact diagnosis related to this impairment.  Caregivers in this 
sample were managing an average of 11 medications as a part of the care-recipient’s daily 
regimen.  These individuals were highly educated, middle class, and caring for moderately 
impaired older adults, and were reporting a moderate level of hassles related to managing the 
Medication Non-Adherence and Dementia  80 
 
care-recipient’s medications.         
 The current study sample exhibits a number of strengths and areas for growth.  In 
general, caregivers in this data set accurately represented overall demographics for caregivers in 
the U.S. in the domains of age and care-recipient diagnosis (Alzheimer's Association and 
National Alliance for Caregiving, 2004). One area of growth in this study, as well as the majority 
of caregiver research, is obtaining a more ethnically diverse sample of participants (Reinhard, 
Given, Petlick, & Bemis, 2008).  Despite high effort to recruit non-white caregivers, with 
particular recruitment attention given to the African American community, the majority of 
caregivers in this study were Caucasian.  Similarly, over half of the caregivers reported a 
household income above $50,000 per year, and the majority had completed the equivalent of a 
college degree.  It is possible that caregivers in lower income communities with differing levels 
of education may perceive the online nature of the study as a barrier, despite the growing trend 
toward increased internet access in these communities (Cohen & Adams, 2009).  Thus, although 
this recruitment difficulty is consistent in the literature (Reinhard, Given, Petlick, & Bemis, 
2008) it presents limitations to the generalizability of these results to non-white, lower income 
and differently educated communities.   
 Pre-Treatment Group Equivalence.  Narrative vignette and comparison didactic group 
participants were approximately equivalent on all pre-treatment demographic variables.  Both 
groups were similar in regards to symptom presentations on primary outcome measures, with the 
exception of three significant differences.  Caregivers in the comparison didactic condition began 
the intervention with higher levels of self-reported medication management hassles; they 
reported hassles approximately 10 points above those of caregivers in the experimental group, 
out of a possible 120 points (Travis, Kao, & Acton, 2005).  Didactic group caregivers reported 
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more polypharmacy related concerns at time one, such as keeping multiple prescriptions filled 
and managing prescriptions by multiple providers.  They also endorsed being more hassled by 
medication issues related to safety, such as recognizing adverse side effects in the care recipient 
and knowing how to give the medication safely.  These initial discrepancies could have impacted 
the ability to detect between-group differences.  Because caregivers in the didactic condition 
reported higher initial levels of hassles, they had greater room for improvement during the 
intervention study.  Conversely, the experimental group would experience a “floor effect,” and 
have significantly lower room for improvement throughout the intervention. This failure in group 
equivalency may have reduced the ability of the study to find significant between group 
differences on changing levels of hassle pre and post-intervention. 
Analysis of Dropout.  Participant dropout in the current study was approximately 34% 
across both treatment conditions.  No significant differences arose in the number of participants 
who dropped out of treatment between the comparison didactic condition and the narrative 
vignette condition.  Similarly, there were no differences in ethnicity, income, level of education, 
level of care provided, or on the multiple indicators of subjective distress between the treatment 
completers and non-completers. Thus, the intervention exhibited a strength in that once 
participants were enrolled in the study, the treatment was tolerated equivalently well across 
multiple caregiver demographic groups.          
 Significant differences were found in participant dropout on care-recipient levels of 
impairment.  Those who dropped out of treatment were providing care to persons who were less 
impaired than those who completed the intervention study, as measured by the analogue CDR 
and ability to complete ADLs.  One hypothesis for this discrepancy is differing caregiver 
perceptions about level of need for treatment, between those providing care for more impaired 
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and less impaired elders.  Multiple behavioral health models, such as the Health Belief Model 
and the Protection Motivation Theory, postulate, and have shown good evidence, that 
intervention participants must first believe that they are at risk for a particular concern, before 
they are effectively able to consider it as a relevant problem, and engage in treatment for this 
difficulty (Abraham & Sheeran 2004; Norman, Boer & Seydel, 2005).  It is possible that 
caregivers providing aid to those with more impairment saw the intervention as more relevant to 
their current problems, whereas those providing care to an older adult with less impairment did 
not see the intervention as germane to their current difficulties.  If true, this is unfortunate, as 
most neurocognitive disorders are progressive (Alzheimer’s Association, 2012).  By the very 
nature of neurocognitive illness, care-recipient level of impairment will increase over time and 
topics that were initially less applicable may rapidly become necessary areas of focus for the 
caregiver.           
 Lastly, it is important to note that caregivers who were expressing a greater degree of 
medication related hassles and poorer medication management adherence were more likely to 
drop out of treatment.  If primary analyses had found significant differences between treatment 
groups on these outcome variables, further examination would be required to ensure that 
differential dropout did not occur between conditions, and artificially indicate treatment efficacy 
that could be attributed to dropout.  As noted below, between group differences did not arise, 
however, thus negating the need for this inquiry.  In addition, this finding raises concern of 
intervention tolerability for individuals that are most in need of treatment.  Although the 
intervention was tolerated well by multiple demographic groups, it may have been more difficult 
to complete for individuals with a higher severity of medication related concerns. 
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Hypothesis 1 Discussion 
 Hypothesis one postulated that participants in the narrative vignette condition would 
show greater levels of satisfaction with the intervention, than participants in the didactic 
comparison condition, at the post-treatment assessment.  No significant differences were found 
between group levels of satisfaction.  Intervention related satisfaction scores were high for both 
conditions, in the mid-forties, out of a total of 56 possible points.  On average, participants 
reported that they were “satisfied,” or “very satisfied,” in most domains of the intervention, 
including the tolerability of treatment.  The tolerability of an intervention is a critical variable in 
influencing participant retention in psychological and behavioral health related interventions, as 
well as participant treatment engagement (Epstein, Thomson, Collins, & Pancella, 2009).  It is 
especially noteworthy that both groups found the interventions to be equally tolerable, as the 
narrative condition contained a greater number of available video resources for treatment.  Thus, 
participants in the narrative condition viewed larger numbers of treatment materials and reported 
similar satisfaction levels with the intervention, indicating that the increased level of materials 
may not have been a significant burden on caregiver time.  This is relevant in the current 
caregiver population, as these individuals typically report being pressed for time, especially 
members of a sandwich generation, who provide care for both children and older loved ones 
(Steffen et al., 2002). 
Hypothesis 2 Discussion 
 
 Hypothesis two posited that caregivers in the narrative condition would show greater 
decreases than the comparison didactic group on medication administration hassles, over time.  
There was no significant Time * Condition effect on caregiver self-reported hassles, nor was 
there a significant main effect of time on this variable.  There are a number of possible reasons 
Medication Non-Adherence and Dementia  84 
 
for this finding.  As mentioned above, the groups did not begin at an equivalent level of 
medication administration hassles; the comparison didactic group initially reported greater levels 
of hassle, thus widening the range of possible change scores, and decreasing the possibility that 
the narrative group could show greater levels of change on this variable.  Once again, this study 
was also somewhat underpowered.  Although every effort was made to obtain the initially 
proposed sample size of N=53, only 35 participants successfully completed the study.  To find 
any significant differences, regardless of directionality, the effect size would have to be within 
the “large” categorization of current statistical recommendations (Cohen, 1992).  Analyses of the 
total medication administration hassles and hassles subscale changes across group never reached 
an effect size that would be considered “large.”  As a result, it is unlikely that current statistical 
analyses would have the power to find a significant result.  Lastly, it is also possible that this was 
a correct acceptance of the null hypothesis, that treatment condition did not differentially impact 
caregiver medication administration hassles over time. 
Hypothesis 3 Discussion 
 
Hypothesis three predicted that the narrative group participants would show a greater 
increase in self-reported positive communication behaviors with medical providers, compared to 
the comparison didactic condition, over time.  There was no significant Time * Condition effect 
or main effect of time on this variable.  Once again, possible reasons for these results include the 
low power available for study, due to a small sample size.  Effect size analyses revealed only a 
small p
for this result, and an observed power of .36, indicating a 36% likelihood of detecting 
statistical significance and correctly rejecting the null hypothesis if p < .05.   
In addition, it is also possible that neither treatment group had the opportunity to re-
assess their current communication behaviors with medical providers, in real medical 
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appointments, within the month-long time period of the study.  As such, there may not have been 
an opportunity for caregivers to notice a change in their behaviors within this context.  Of course, 
the final possibility remains that this study correctly accepted the null hypothesis, that there was 
no differential intervention group impact on patient-provider communication over time. 
Hypothesis 4 Discussion 
Hypothesis four predicted that narrative group participants would show greater 
improvements in medication adherence behaviors for care-recipient medication regimens, 
compared to didactic group participants, over time.  Analyses revealed that there was no 
significant Time * Condition effect nor was there a main effect of time on medication adherence 
behaviors.  Once again, this analysis suffers from the same low statistical power and small effect 
size as was present in previous analyses.  The corresponding difficulty in finding statistically 
significant results remains a consideration in this analysis (Cohen, 1992).  As mentioned above, 
for hypothesis 3, it is also possible that the month-long intervention progression did not provide 
caregivers with adequate time to have re-adjusted their medication management behaviors and to 
report on said adjustments.  This might be especially true in cases where caregivers exhibited the 
majority of their resource views in the final week of the intervention. Again, the final possibility 
also remains that this study correctly accepted the null hypothesis, that there was no differential 
intervention group impact on caregiver medication adherence behaviors, over time. 
Hypothesis 5 Discussion 
Hypothesis five postulated that narrative group participants would show greater increases 
in self-efficacy for controlling upsetting thoughts related to the caregiving situations, compared 
to didactic group participants, over time.  Analyses revealed a non-significant Time * Condition 
effect on self-efficacy, but a significant main effect of time on caregiver self-efficacy for 
controlling upsetting thoughts.  Thus, the composite improvement scores in both groups’ level of 
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self-efficacy, was found to be significant.  Once again, however, it is possible that due to the 
small sample size, the correspondingly low power and the small effect sizes observed for this 
analysis, the study did not have the power necessary to be able to detect statistically significant 
differences between groups.  This assertion may be correct, as trends in the data suggest that 
although both groups show increased self-efficacy for controlling upsetting thoughts over time, 
the narrative condition exhibits greater trends in this direction. 
Secondary analyses for hypothesis 5 revealed a significant within-group effect in the 
narrative condition; caregivers receiving this treatment showed significant increases in total 
levels of self-efficacy for controlling upsetting thoughts from pre-intervention to post-
intervention.  Specifically, participants in the narrative condition reported improved ability to 
control upsetting thoughts about “how unfair the caregiving situation is,” “unpleasant aspects of 
the caregiving situation,” and “worries about the future.”   Based on these findings, it is possible 
that caregivers in the narrative group were effectively able to build self-efficacy through 
vicarious experiences of similar others in the narrative web episodes (Bandura, 1977; Bandura, 
1982; Bandura, 1994).  This is a promising finding, as improved self-efficacy has been linked to 
one’s ability to persist in tasks despite obstacles, and to learning new behaviors (Bandura, 1982; 
Bandura, 1994; Bandura, 1997).  As a result, this increase in self-efficacy may correlate with 
other long-term improvements in health management domains of caregiving.   
 Despite the possibility that this improvement may be attributable to the intervention, it is 
also possible that internal threats to validity, such as maturations, regression toward the mean 
and repeated assessment, have impacted this finding (Kazdin, 2003).  It is difficult, without 
further data, to attribute this finding exclusively to the impact of the intervention.  A “no-
treatment” or waitlist control would be beneficial in further exploring this result.  
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Evaluation of Research Methodology 
Strengths.  This study included several novel components that served as strengths and 
useful contributions to the present state of caregiving literature.  Firstly, the intervention 
developed for this manuscript was one of very few health education treatments that focused on 
care dyads of a person with cognitive impairment (Banning, 2009; Conn et al., 2009).  Current 
studies meeting these criteria, often lack clear theoretical underpinnings in their intervention 
development, and only include older adults with minimal cognitive concerns (Banning, 2009; 
Conn et al., 2009).  The present intervention, however, has clear theoretical groundings in 
Bandura’s Social Cognitive Theory, while including caregivers of more impaired elders.  In 
addition, this is the first randomized health education intervention developed to focus largely on 
caregivers.  The majority of current studies focus on healthcare modifications for the cognitively 
impaired older adult, while entirely neglecting the likelihood that there may be an involved 
informal care partner (Kamimura, Ishiwata & Inoue, 2012).       
 In addition, the current intervention is the first health education treatment available to 
caregivers in an online format.  This is beneficial, as the number of individuals using online 
resources, across generations, continues to increase (Cohen & Adams, 2009; Pew Research 
Center, 2011).  Those in lower income communities also report increasing access to technology 
and the internet through the use of smart phones (Cohen & Adams, 2009), and most individuals 
who seek out healthcare information use online searches, at some point during the process (Pew 
Research Center, 2011).  Finally, many studies show that caregivers have increased time-
constraints when compared to similar non-caregiving individuals (Schulz & Martire, 2004).  The 
online availability of interventions may decrease the time investment necessary for caregivers to 
easily obtain aid.            
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 Another strength of the intervention is the flexible content approach.  Caregivers in this 
study were able to log into the website at any time of day and spend as much time as they 
believed necessary on the intervention website.  In addition, they were able to select any content 
area and any video or PDF resources that interested them as a part of their own individualized 
treatment program.  The tailored and individual specific nature of this intervention is a 
significant asset, as psychological treatment literature suggests that this is linked to increased 
retention of participants as well as improved outcomes (Epstein, Thomson, Collins, & Pancella, 
2009; Epstein, Collins, Thomson, & Pancella,  2007; Epstein & McGaha, 1999).   
Limitations & Future Directions.  The present study also had several limitations.  In 
general, the sample size was lower than necessary to obtain power sufficient for detecting 
statistically significant changes between groups.  In addition, secondary analyses lack a 
comparison group, such as a no-treatment control or a waitlist control.  Although this study 
included a narrative condition and comparison didactic condition, there was no way to discern if 
within group changes would have occurred without any form of intervention from the 
researchers.  It is difficult to positively attribute within-group changes over time to an 
intervention effect rather than to threats to internal validity such as multiple assessment or 
maturation.  Further, many of the currently measured medication and healthcare related 
behaviors may be low base-rate events and as such, ideal measurement of change should occur 
over a period of time that is greater than one month.  Future studies that seek to replicate and 
explore these findings through longitudinal measurement and may wish to include a third, no 
treatment control group, or waitlist control group that can be used as a comparison.   
 In addition, this study may have reduced external validity in caregivers who are non-
white, lower income or who demonstrate lower educational attainment.  It is possible that the 
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decreased level of recruitment for these individuals reflects a bias in these communities for lower 
access to technological resources (Pew Research Center, 2011), or it may reflect the traditional 
pattern of these underserved populations to show lower general engagement with healthcare and 
health related interventions, based on historical interactions with healthcare communities 
(Commission on Social Determinants of Health, 2008; Office of Minority Health, 2011).  Future 
studies may benefit from anticipating these potential recruitment barriers, and remedy this by 
singularly targeting individuals in these underserved communities.  Similarly, future studies may 
explore the current barriers to technological access and eliminate these by providing other 
avenues to internet resources (i.e. library cards or rented tablets).    
 Other areas for growth may include attempts to utilize this intervention in spousal 
caregivers, caregivers of persons without dementia, and exploring intervention response between 
rural and urban caregivers.  It would also be beneficial to identify the most salient intervention 
components contributing to caregiver improvement over time.  As is traditional with the 
trajectory of most early intervention trials, future studies should seek to establish effectiveness, 
rather than efficacy, in larger populations that includes a broader swath of caregivers (Kazdin, 
2003).  Dismantling trials, after establishing efficacy of the intervention, may be useful in 
determining the “active ingredients,” involved in producing positive caregiver change (Kazdin, 
2003).  Because this study occurred over a relatively brief time frame (1 month), future research 
may further benefit from extending the amount of follow-up contact and assessment points as 
well as including a qualitative component regarding caregiver’s experiences during the 
intervention trial.  
Clinical Considerations.  The current finding that narrative intervention participants saw 
improved self-efficacy for controlling upsetting thoughts, has several clinical implications.  This 
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noted increases in self-efficacy could have benefits related to improved mood management in 
caregivers (George & Steffen, 2015), increased ability to tolerate distress in the caregiving 
situation, ability to persist in learning new behaviors, (Bandura, 1977; Bandura, 1982; Bandura, 
1994), and may be linked to other positive health management behaviors for the older loved one.  
Improving caregiver self-efficacy for controlling upsetting thoughts may have other unforeseen 
positive consequences, such as reduced need for caregiver utilization of psychotropic 
medications (George & Steffen, 2015).  Clinical access points for caregiver introduction to this 
intervention, may include Emergency Departments, which often serve as primary care for 
underserved populations (Commission on Social Determinants of Health, 2008) or primary care 
clinics, the first contact point for older adults and caregivers who are noting cognitive concerns 
(Boise, Neal, & Kaye, 2004; Forester & Oxman, 2003).   
Conclusions 
 This study investigated the efficacy of an online health education intervention, designed 
to improve caregiver medication management of a cognitively impaired care-recipient’s 
medication regimen.  Women caring for an older generation, cognitively impaired loved one, 
were randomized to one of two treatment conditions; the narrative vignette group or the didactic 
comparison condition.  Participants in this study were asked to complete pre-assessment 
measures assessing caregiver medication administration hassles, patient-provider 
communication, medication management adherence, and self-efficacy for controlling upsetting 
thoughts.  Afterwards, they engaged in a 1-month online health education intervention, and filled 
out similar post-assessment questionnaires directly following completion of the intervention.  
Strengths of this study include targeting a novel population for medication management in older 
adults with dementia, creation of a flexible online format that allowed caregivers to explore 
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health education content areas of most interest to them, and a theoretical basis in Social cognitive 
theory.            
 The findings of this study were mixed and require further future exploration.  Although 
the didactic and narrative treatment groups did not differ from one another on improvement in 
the aforementioned areas, there was a significant main effect of time on caregiver self-efficacy 
for controlling upsetting thoughts.  Participants in the narrative vignette condition, specifically, 
showed significant overall improvement in self-efficacy for controlling upsetting thoughts, over 
time.  There were no differences in intervention group levels of satisfaction at post-treatment, 
suggesting similar levels of tolerability between conditions.      
 Overall, this study provides the groundwork necessary implementation of health 
education interventions in care dyads.  Future research should seek to replicate these findings, 
while including a no-treatment or waitlist control for comparison to the already developed 
treatment conditions.  In addition, future studies would benefit from exploring the external 
validity of this intervention in underserved populations, broadening the possible treatment 
populations, and completing dismantling studies to determine the effective components of the 
present health education treatment. 
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Appendix A. 
 
Contact Timeline for Intervention Groups 
 
Narrative Group Contact Timeline Didactic Group Contact Timeline 
 Participant completes screening 
assessment.  Assessment program 
emails project coordinator that 
someone has qualified for project. 
 Participant completes screening 
assessment.  Assessment program 
emails project coordinator that 
someone has qualified for project. 
 Project Coordinator Sends “Email 
1/ Introductory assessment email ” 
 Record date email was sent in the 
participant tracking form. 
 Project Coordinator Sends “Email 1/ 
Introductory assessment email ” 
 Record date email was sent in the 
participant tracking form. 
 The 4th pre-assessment survey 
generates an automatic email when 
completed. 
 The 4th pre-assessment survey 
generates an automatic email when 
completed. 
 Send email 2 “Introduction to 
intervention with login ID and 
password: Experimental Condition” 
 In sandwichgenerationdiner.com 
assign login ID, password and User 
Level one for narrative condition. 
 Send email 2 “Introduction to 
intervention with login ID and 
password: Control condition” 
 In sandwichgenerationdiner.com 
assign login ID, password and User 
Level one for didactic condition. 
 One week later, send “email 3, after 
one week” 
 Increase Participant access level to 
week 2 of narrative condition. 
 One week later, send “email 3, after 
one week” 
 Increase Participant access level to 
week 2 of didactic condition. 
 One week later send “email 4 after 
2 weeks” 
 Increase participant access level to 
week 3 of narrative condition. 
 One week later send “email 4 after 2 
weeks” 
 Increase participant access level to 
week 3 of didactic condition. 
 One week later send “email 5 after 
3 weeks” 
 Also Send the “5 wishes email” 
 Increase participant access to week 
4 (final level) of narrative 
condition. 
 One week later send “email 5 after 3 
weeks” 
 Also Send the “5 wishes email” 
 Increase participant access level to 
week 4 (final level) of didactic 
condition 
 One week later, a total of 4 weeks 
after the login ID email, send the 
“post-test assessment” email 
 One week later, a total of 4 weeks 
after the login ID email, send the 
“post-test assessment” email 
 The 4th survey in this group 
generates an automatic email when 
completed. 
 
 The 4th survey in this group 
generates an automatic email when 
completed. 
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Appendix B 
Treatment Condition Content Areas 
 
Week 
 
 
Narrative condition 
 
Didactic Condition 
1 
 
Medication Management 
 Organizing Meds (PDF) 
 Introduction (Dyad Video) 
 Organizing Meds (Dyad Video ) 
Talking Together 
 Basic Communication Tips (PDF) 
 Introduction (Dyad Video) 
 Basic Communication (Dyad Video)  
Signs of Confusion 
 Causes of Confusion (PDF) 
 Causes of Confusion (Expert Video) 
 10 Warning Signs (PDF) 
 Introduction (Dyad video) 
 Causes of Confusion (Dyad Video) 
Healthcare Visits 
 Getting Ready for a Healthcare Visit 
(PDF) 
 Introduction (Dyad Video) 
 Getting Ready (Dyad Video) 
 
Medication Management 
 Organizing Meds (PDF) 
Talking Together 
 Basic Communication Tips 
(PDF) 
Signs of Confusion 
 Causes of Confusion (PDF) 
 Causes of Confusion 
(Expert Video) 
 10 Warning Signs (PDF) 
Healthcare Visits 
 Getting Ready for a 
Healthcare Visit (PDF) 
 
2 Medication Management 
 Ask Your Pharmacist (PDF) 
 Ask Your Pharmacist (Expert Video) 
 Ask Your Pharmacist (Dyad Video ) 
Talking Together 
 Handling Minor Disagreements (PDF) 
 Minor Disagreements (Dyad Video) 
Signs of Confusion 
 Why get a Diagnosis (PDF) 
 Getting a Diagnosis Step 1 (Dyad Video) 
Healthcare Visits 
 Learning about Meds (PDF) 
 Learning about Meds (Dyad Video) 
Medication Management 
 Ask Your Pharmacist 
(PDF) 
 Ask Your Pharmacist 
(Expert Video) 
Talking Together 
 Handling Minor 
Disagreements (PDF) 
Signs of Confusion 
 Why get a Diagnosis 
(PDF) 
Healthcare Visits 
 Learning about Meds 
(PDF) 
 
3 Medication Management 
 Over the Counter Meds (PDF) 
 Taking Time for More Questions (PDF) 
Medication Management 
 Over the Counter Meds 
(PDF) 
 Taking Time for More 
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 Taking Time for More Questions (Dyad 
Video ) 
Talking Together 
 Handling Major Disagreements (PDF) 
 Major Disagreements (Dyad Video) 
Signs of Confusion 
 Getting a Diagnosis (PDF) 
 AD8 (PDF) 
 Getting a Diagnosis Step 2 (Dyad Video) 
Healthcare Visits 
 Release Forms (PDF) 
 Side Effects (PDF) 
 Side Effects (Expert Video) 
 Release Forms and Side Effects (Dyad 
Video) 
Questions (PDF) 
Talking Together 
 Handling Major 
Disagreements (PDF) 
Signs of Confusion 
 Getting a Diagnosis (PDF) 
 AD8 (PDF) 
Healthcare Visits 
 Release Forms (PDF) 
 Side Effects (PDF) 
 Side Effects (Expert 
Video) 
 
4 Medication Management 
 Fine Tuning Questions For Your 
Pharmacist (PDF) 
 Fine Tuning (Dyad Video) 
Talking Together 
 Planning for the Future (Expert Video) 
 Housing Plans (PDF) 
 Transportation Plans (PDF) 
 Healthcare Plans (PDF) 
 Long Term Plans (PDF) 
 Financial Plans (PDF) 
 Values and Plans (Dyad Video) 
Signs of Confusion 
 Following a Dementia Diagnosis (PDF) 
 Following a Dementia Diagnosis (Dyad 
Video) 
Healthcare Visits 
 Affording Meds (PDF) 
 Affording Meds (Dyad Video) 
Medication Management 
 Fine Tuning Questions For 
Your Pharmacist (PDF) 
Talking Together 
 Planning for the Future 
(Expert Video) 
 Housing Plans (PDF) 
 Transportation Plans (PDF) 
 Healthcare Plans (PDF) 
 Long Term Plans (PDF) 
 Financial Plans (PDF) 
Signs of Confusion 
 Following a Dementia 
Diagnosis (PDF) 
Healthcare Visits 
 Affording Meds (PDF) 
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Appendix C 
Timeline for Project 
Study Start up – July 2013  Dec 2013 
Recruitment- December 2013  October 2014 
Intervention- December 2013  October 2014 
Analysis and Writing- October 2014  April 2015 
 
 
 
 
 
 
 
 
Study Start up 
July 2013- 
December 
2013 
Recruitment 
and 
Intervention 
Dec 2013- Oct 
2014  
Analysis and 
Writing 
Oct 2014- April 
2014 
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Appendix D 
Student Duties 
 
Startup  
•Time investment: 20- 40 hours per week 
•Creation of Intervention 
•Create all Didactic Handouts 
•Provide outlines for script writers detailing narrative vignette content 
areas based in self-efficacy theory 
•Revise script 
•Consult with healthcare professionals about didactic content  
•Consult with web designers about layout of intervention website and 
issues of online measurement and assessment/ screener set-up 
•Measure Selection 
•Create and Submit IRB for Intervention 
•Create all online assessments  and screens through Qualtrics 
Recruitment 
•Time investment: 20-40 hours per week 
•Perform all recruitment duties and project management 
Intervention 
•Time investment: 20-40 hours per week 
•Monitor each individual's intervention progress 
•Send reminder emails for individual participation 
•Direct participant financial compensation 
•Provide Tech Support 
Analysis and Writing 
•Perfrom all duties related to dissertation analysis and writing 
